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Abstract 
A subset of eukaryotic heterochromatin is located around the nucleoli, and 
this localization is correlated with gene silencing. Although there is some 
evidence for trans-acting factors organizing genomic loci around the nucleolus, 
the characterization of proteins and /or RNAs involved in perinculeolar 
heterochromatin organization is incomplete. Notably, the mammalian female 
inactive X chromosome, a well-studied model of facultative heterochromatin, 
frequently resides in the perinucleolar regions during S phase. The disruption of 
the Xi–nucleolus association results in the erosion of several features of 
heterochromatin and silencing, which renders it a good model to investigate the 
mechanism and biological relevance of perinucleolar heterochromatin 
organization. This dissertation will present evidence showing that Ki-67 regulates 
Xi association with nucleoli, maintains Xi heterochromatic structures, and 
regulates cell cycle progression in cell-type-specific manner dependent on 
checkpoint proficiency.   
Upon Ki-67 depletion, the Xi from a subset of human female hTERT-RPE1 
cells moved away from the nucleolus and displayed several features of 
compromised heterochromatin. These chromatin alterations were limited to Xi 
chromosomes localized away from the nuclear lamina and were not observed in 
293T cells upon Ki-67 depletion. Furthermore, different Xi heterochromatin 
alteration responses result from cell-type-specific reduced proportion of cells in S 
	   VII	  
phase upon Ki-67 depletion. In human hTERT-RPE1, WI-38, IMR90 and hTERT-
BJ cell lines, depletion of Ki-67 slowed entry into S phase and coordinately 
downregulated DNA replication genes. These cell lines are able to induce p21 
expression upon Ki-67 depletion. On the contrary, alteration of transcription and 
cell cycle progression were not observed in tumor-derived HeLa, U2OS and 
293T cell lines. These cell lines do not induce p21 expression either.  Overall, our 
results indicate that Ki-67 integrates normal S phase progression and Xi 
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CHAPTER I: INTRODUCTION 
1.1 Abstract 
This dissertation is focused how Ki-67 regulates perinucleolar 
heterochromatin organization in respond to cell cycle progression. Ki-67 has long 
been used as clinical marker of cell proliferation to grade tumors. Despite the 
strict correlation between Ki-67 expression and cell proliferation, differing results 
have been obtained in the test of requirement of Ki-67 in cell growth. Recent 
studies identified that Ki-67 acts as trans-acting factor to promote alpha satellite 
repeats to perinucleolar regions. But the mechanisms by which Ki-67 coordinates 
cell cycle progression with perinucleolar heterochromatin organization remain 
incomplete. Inactive X chromosome (Xi) is a well-studied example of facultative 
heterochromatin that associates with the nucleoli of female mouse and human 
cells in mid-to-late S phase. Trans-acting proteins and the RNAs are required to 
target Xi to perinucleolar regions. This chapter will summarize the dynamics, 
mechanisms and functional implications of perinucleolar localization of Xi and 
other genomic loci. 
1.2: Ki-67 
Ki-67 was first identified as an antigen in Hodgkin lymphoma cell nuclei 
(Gerdes et al., 1983) that is highly expressed in cycling cells but strongly down-
regulated in resting G0 cells (Gerdes et al., 1984). This characteristic has made 
Ki-67 a clinically important proliferation marker for grading multiple types of 
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cancers (Gerdes et al., 1987; Dowsett et al., 2011), with well-established 
prognostic value in large studies(Luo et al., 2015; Pyo et al., 2015; Richards-
Taylor et al., 2015; Pezzilli et al., 2016). Despite this broad medical utility, 
surprisingly little is known about the molecular functions of Ki-67. Here, I review 
recent studies that have uncovered roles for Ki-67 in cell cycle regulation, 
heterochromatin maintenance, and assembly of the perichromosomal layer on 
mitotic chromosomes.(Booth et al., 2014; Sobecki et al., 2016; Cuylen et al., 
2016)  
1.2.1: Ki-67 structure 
Ki-67 protein is highly conserved in vertebrates (Booth and Earnshaw, 
2017). In humans, Ki-67 is encoded by the gene MKI67 located on chromosome 
10q. Alternative splicing of the Ki-67 mRNA generates two isoforms with 
molecular weight of 320kDa and 359kDa. Functional differences between these 
isoforms have not been described, however, this huge nuclear protein does 
contain several characterized functional regions.  
The N-terminus of Ki-67 contains a forkhead associated domain 
(FHA)(Takagi et al., 2001), a motif that preferentially recognizes phosphorylated 
protein epitopes (Durocher et al., 1999; Durocher and Jackson, 2002). Via this 
FHA domain, Ki-67 interacts with two proteins during mitosis: phosphorylated 
kinesin-like motor protein Hklp2/Kif15 and phosphorylated nucleolar RNA-binding 
protein NIFK (Takagi et al., 2001; Sueishi et al., 2000; Durocher and Jackson, 
2002). The interaction between Ki-67 and Hklp2 contributes to mitotic spindle 
stability (Vanneste et al., 2009). Hklp2 is a plus-end-directed spindle 
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motor(Vanneste et al., 2009). In mitotic cells, Hklp2 distributes between 
microtubules and chromosomes. Upon Ki-67 depletion, Hklp2 fails to localize to 
the chromosome and concentrates in microtubules. More microtubule associated 
Hklp2 generates more pushing forces on spindles and metaphase spindles 
become longer than the control cells(Vanneste et al., 2009). NIFK promotes cell 
proliferation and cancer metastasis (Pan et al., 2015; Lin et al., 2016). 
Downregulation of NIFK in H661 and H1299 cells reduced cancer cell growth(Lin 
et al., 2016). Conversely, in both A549 and PC13 lung cancer cell lines, 
overexpression of wild type NIFK but not mutants lacking the Ki-67 binding motif 
increase cell proliferation (Lin et al., 2016). NIFK enhances the metastatic ability 
of lung cancer cells via destabilizing transcription factor RUNX1, which in turn 
promotes a pro-metastatic Wnt/β-catenin signaling pathway (Hernandez et al., 
2012; Li et al., 2012). Notably, repression of RUNX1 is largely attenuated when 
NIFK is incapable of Ki-67 binding (Lin et al., 2016). Therefore, the pro-
proliferative activities of NIFK are exerted in complex with the Ki-67 FHA domain. 
An additional activity has been mapped to the Ki-67 FHA domain. In the 
tumor-derived DLD-1 cell line, the Ki-67 FHA domain maintains expression of 
cancer stem cell markers CD133 and CD44 (Cidado et al., 2016). It would 
therefore be of interest to know whether FHA-mediated cancer stem cell 
maintenance is also dependent on the NIFK protein.	   
All homologues of Ki-67 contain a canonical Protein Phosphatase 1 (PP1) 
binding motif (RVxF)(Booth et al., 2014). The PP1 family contains three isoforms, 
PP1	   α, PP1β, and PP1γ and is predicted to catalyze approximately one third of 
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all eukaryotic protein dephosphorylation events, spanning a wide variety of 
cellular functions (Rebelo et al., 2015). The versatility of PP1 functions is largely 
determined by the binding of its catalytic subunits to different regulatory proteins 
that define when and where the phosphatase acts (Rebelo et al., 2015). In a ~40 
residue region containing the PP1 binding motif, Ki-67 displays high similarity to 
the PP1-interacting protein, RepoMan(Booth et al., 2014), which contributes to 
targeting PP1γ to anaphase chromosomes (Trinkle-Mulcahy et al., 2006). In vivo, 
both Ki-67 and RepoMan bind specifically to PP1β and PP1γ isoforms, but not to 
PP1α	   (Booth et al., 2014)(Kumar et al., 2016).	  Crystal structures of Ki-67:PP1γ 
and RepoMan:PP1γ holoenzyme complexes identified a supplementary, novel 
PP1 interaction motif termed KiR-SLiM (Ki-67-RepoMan small linear motif), which 
is just C-terminal to the canonical RVxF motif (Kumar et al., 2016). Ki-67 and 
RepoMan are the only known PP1 interactors that require this additional motif for 
binding (Kumar et al., 2016). Because PP1 has 200 interacting/regulator proteins, 
KiR-SLiM:PP1 interaction surface could be a candidate drug target that inhibit 
only 2 PP1 holoenzymes in the cell(Rebelo et al., 2015). Ki-67 /PP1 holoenzyme 
is a functional phosphatase complex in vivo. It dephosphorylates S125 on 
nucleophosmin/B23. Following Ki-67 depletion, phosphorylation on S125 of 
nucleophosmin/B23 is significantly increased(Booth et al., 2014). 
The central region of Ki-67 is comprised of multiple tandem repeats that 
are phosphorylated by CDK1 during mitosis (Schluter et al., 1993; MacCallum 
and Hall, 1999; Endl and Gerdes, 2000; Takagi et al., 2014). Ki-67 localization 
and dynamics are controlled by phosphorylation. In interphase, 
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dephosphorylated Ki-67 tightly associates with chromatin and localizes to the 
nucleolus in human cell lines (Saiwaki et al., 2005).  During mitosis, 
hyperphosphorylated Ki-67 binds less avidly to DNA and is highly mobile on the 
chromosome periphery (MacCallum and Hall, 1999; Endl and Gerdes, 2000; 
Saiwaki et al., 2005).  Dephosphorylation of mitotic Ki-67 delocates it away from 
the perichromosomal layer (MacCallum and Hall, 1999).  On the mitotic 
chromosome surface, the highly positive electrostatic charge of Ki-67 serves as 
an electrostatic barrier important for prevention of hyperaggregation of 
chromosome arms. This will be discussed in more detail in 1.2.3 (Cuylen et al., 
2016).  
Ki-67 has a weakly conserved leucine/arginine-rich C-terminal domain (LR 
domain) which can bind to DNA in vitro (Takagi et al., 1999; Scholzen et al., 2002) 
and is required for association with chromosomes in living cells (Saiwaki et al., 
2005; Cuylen et al., 2016). This C-terminal domain of human Ki-67 binds all three 
isoforms of heterochromatin protein 1 (HP1) in vitro and in vivo (Kametaka et al., 
2002; Scholzen et al., 2002). Via its methyllysine-binding chromodomain, HP1 
binds to the hallmark of constitutive heterochromatin, di- and tri-methylated 
histone H3K9 residues(Jacobs and Sepideh, 2002; Nielsen et al., 2002). By 
reading H3K9 methyl marks and recruiting histone methyltransferase and 
chromatin assembly factor 1 complex (CAF-1), HP1 facilitates assembly and 
maintenance of constitutive heterochromatin that contains centromeres and 
telomeres and remains compact in every cell type(Quivy et al., 2004; Hiragami-
Hamada et al., 2016). Therefore, the interaction with HP1 suggests 
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heterochromatic roles for Ki-67. Indeed, overexpression of the human, chmadrin 
or Xenopus Ki-67 produces accumulation of HP1 and H3K9me3 and induces 
ectopic heterochromatin formation. (Takagi et al., 1999; Scholzen et al., 2002) 
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Figure 1.1   A schematic diagram of human Ki-67 structure 
FHA: forkhead-associated domain 
PP1: PP1 binding domain 




1.2.2:  Ki-67 expression during the cell cycle 
The initial characterization of Ki-67 localization detected a nuclear protein 
in proliferating human cells (Gerdes et al., 1983). Additionally, studies of 
phytohemagglutinin (PHA)-stimulated peripheral mononuclear blood leukocytes 
(PBL) showed that unstimulated (G0 phase) cells were negative for the Ki-67 
antigen (Gerdes et al., 1984). We now know that the MKI67 gene promoter itself 
is cell cycle-regulated, containing binding sites for the canonical G1-regulatory 
E2F family of transcription factors (Ishida et al., 2001), and that Ki-67 mRNA 
levels increase during G1 (Sobecki et al., 2016; Sobecki et al., 2017). Ki-67 
protein degradation also occurs during G1 via ubiquitin proteasome complex 
APC/C-Cdh1 (Chierico et al., 2017; Sobecki et a.,2017). Therefore, Ki-67 protein 
concentrations in G1 are controlled by two opposing mechanisms. In addition, 
unlike deeply quiescent or senescent cells, cells in early stages of cell cycle 
arrest have low levels of Ki-67, which can carry over after re-entering the cell 
cycle (Sobecki et al., 2017). Therefore, slight variation in the degree of 
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quiescence can result in variable Ki-67 levels in the first G1 phase after cell cycle 
re-entry, likely contributing to variable observations of in different experiments 
(Gerdes et al., 1984; Lopez et al., 1991; Sobecki et al., 2017).  
1.2.3: Ki-67 coats mitotic chromosomes 
In the past few years, several studies have greatly increased our 
understanding of Ki-67’s mitotic functions. As cells enter mitosis, chromosomes 
undergo a remarkable series of structural transformations known as chromosome 
condensation. A proteinaceous sheath termed the perichromosomal layer (PCL) 
exists at the outer surfaces of individual chromosomes (Hernandez-verdun and 
Gautier, 1994; Van Hooser et al., 2005). Ki-67 is one of the earliest proteins 
associated with this structure and remains on it until telophase (Van Hooser et al., 
2005). Several studies have found that Ki-67 is required for the formation of the 
human PCL. Acute depletion of Ki-67 in human cells caused dispersal of all other 
non structure layer components tested, including nucleolin, nucleophosmin, NIFK, 
cPERP-B, cPERP-C, cPERP-D and cPERP-F.  Conversely, depletion of these 
components did not alter perichromosomcal localization of Ki-67 (Booth et al., 
2014). The abnormal localization of nucleolar components during mitosis in turn 
leads to their asymmetric distribution in daughter cells(Booth et al., 2014). A 
recent study shows that CAF-1 p150, the largest subunit of histone chaperone 
Chromatin Assembly Factor-1 (CAF-1) regulates normal levels of Ki-67 
accumulation on the PCL. This activity was mapped to the sumoylation 
interacting motif (SIM) within p150, which was also required for the localization of 
	   9	  
Ki-67 and nucleolus association domain to the nucleolus during interphase(Smith 
et al., 2014).  
While the function of Ki-67 on PCL is still being explored, one recent study 
suggests that Ki-67’s large size and high density of positively charged amino 
acids causes it to act as a surfactant, keeping mitotic chromosomes from 
aggregating (Cuylen et al., 2016). Upon Ki-67 depletion, adhesion between 
neighboring mitotic chromosomes impaired spindle assembly and metaphase 
plate formation. As a result, in HeLa cells, depletion of Ki-67 impaired access of 
spindle microtubules to chromosomes, and chromosome alignment during 
metaphase and caused a prolonged mitosis (Starborg et al., 1996; Vanneste et 
al., 2009) 
1.2.4: Is Ki-67 required for proliferation  
Although Ki-67 expression is tightly correlated with proliferation, differing 
results have been obtained in tests of the role of Ki-67 in cell growth. In early 
studies, microinjection of an anti-Ki-67 antibody inhibited proliferation of Swiss 
3T3 cells (Starborg et al., 1996). Likewise, human tumor cell lines, including 
human IM-9 multiple myeoloma, RT-4 bladder carcinoma, and 786-0 renal 
carcinoma cells reduced proliferation rate upon treatment of either Ki-67 targeted 
anti-sense oligonucleotides or si-RNA(Schluter et al., 1993; Zheng et al., 2006). 
Also, light-mediated inactivation of chromophore-marked Ki-67 inhibited 
ribosomal RNA synthesis in HEP-2 cells (Rahmanzadeh et al., 2007). However, 
another study did not detect altered ribosomal RNA production upon Ki-67 
depletion in several cancer cell lines tested, including HeLa, U2OS and HCT116 
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(Sobecki et al., 2016). Additionally, the cell cycle distribution of HeLa and U2OS 
cells remains unaltered upon depletion of Ki-67 (Sobecki et al., 2016). In human 
MCF-10A epithelial breast and DLD-1 colon cancer cells, loss of Ki-67 does not 
affect cell proliferation in bulk culture but clonogenic growth of highly diluted cell 
population is decreased(Cidado et al., 2016).  These data raise the possibility 
that Ki-67 function may have different consequences in different cell types.  
1.2.5: Interphase Ki-67 organizes heterochromatin 
The finding that Ki-67 colocalized with Hoechst 33258-stained 
chromocenters in mouse Swiss 3T3 fibroblasts during the S and the G2 phase 
indicated that it may play a more general role in heterochromatin organization 
(Starborg et al., 1996). Ki-67 association with heterochromatic regions was also 
detected in early G1 phase cells.  In this case, immuno-FISH experiments 
revealed that Ki-67 localizes to hundreds of distinct foci within two hours after 
mitotic exit (Lopez et al., 1991; Isola et al., 1990). These early G1 foci co-localize 
with several different classes of heterochromatic repetitive elements, including 
centromeric alpha satellite, telomeric repeats, and Satellite III (Bridger et al., 
1998).  Notably, these repeats frequently localize to the nucleolar periphery 
during the rest of interphase.  
These observations are underpinned by several recent studies showing 
that Ki-67 promotes association of multiple heterochromatic regions with the 
nucleolar periphery. Nucleoli are surrounded by a subset of the genome termed 
nucleolar-associated DNA sequences (NADs) (Norton et al., 2009; 
Koningsbruggen et al., 2010; Németh et al., 2010; Dillinger et al., 2016). Multiple 
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studies showed that Ki-67 depletion decreased the nucleolar assocation of NADs, 
including a LacO array proximal to the rDNA repeats on chromosome 13 (Booth 
et al., 2014), or chromosome 17 alpha satellite repeats (Matheson and Kaufman, 
2017b). Additionally, Ki-67 depletion delocalized centromeric histone variant 
CENP-A away from nucleoli, indicating reduced centromeric chromatin 
association with nucleoli (Sobecki et al., 2016).  
How does Ki-67 promote these interactions?  There are several 
possibilities that are not mutually exclusive. These include recognition of primary 
sequences or chromatin features of NADs (Bridger et al., 1998; Kreitz et al., 
2000), via direct interaction(Takagi et al., 1999; Scholzen et al., 2002), or via 
binding of other nucleolar–targeting proteins. Furthermore, RNAs are important 
for several higher order chromosome interactions (Hacisuleyman et al., 2014; 
Yang et al., 2015), including examples at nucleoli (Mondal et al., 2008; Fedoriw 
et al., 2012a) , and these have not been investigated in this regard. Ki-67 may 
also form a charged surface coating on nucleoli in analogy to its role on mitotic 
chromosomes (Cuylen et al., 2016)and thereby attract heterochromatin(Strom 
and Alexander, 2017). It is possible that phase separation of heterochromatin 
could contribute to such a mechanism.  
Besides mediating long-range chromosome interactions, Ki-67 also 
promotes short-range chromatin interactions. Upon Ki-67 depletion, HeLa cells 
displayed reduced forster resonance energy transfer (FRET) signals between 
H2B-eGFP and H2B-mCherry (Sobecki et al., 2016), which reports on inter-
nucleosomal interactions on the scale of ~1-10 nm (Llères et al., 2009).  
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Elimination of condensed FRET signal foci occurring from heterochromatin 
suggests Ki-67 promotes heterochromatin compaction(Sobecki et al., 2016).  
Heterochromatin compaction in most eukaryotes depends on core histone 
deacetylation and histone H3K9 di- and tri-methylation (Eissenberg and Elgin, 
2014).  In the absence of Ki-67, H3K9Me3 and H4K20Me3 become less focally 
clustered(Sobecki et al., 2016). Methylation of H3K9 is recognized by 
HP1(Jacobs and Sepideh, 2002; Nielsen et al., 2002). Ki-67 directly binds HP1 
with high affinity(Kametaka et al., 2002; Scholzen et al., 2002). In HeLa cells, Ki-
67 partly overlaps with HP1 and relocalizes to sites of high ectopic HP1 
expression (Kametaka et al., 2002; Scholzen et al., 2002). The interaction 
between Ki-67 and HP1 may allow Ki-67 to link H3K9me2/3 enriched regions 
with its other interactors that are involved in histone methylation including UHRF1 
that binds H3K9me3 and DNA methyltransferase DNMT1 and components of 
H3K27 methyltransferase complex and H3K4 demethylase complexes(Bostick et 
al., 2007; Sobecki et al., 2016). To further understand how interaction between 
HP1 and Ki-67 contributes to heterochromatin organization, it is improtant to 
examine phenotypes of cells in which Ki-67 can not bind HP1.  
1.3: Heterochromatin compartments   
Chromatin has historically been segregated into two categories, 
depending on how densely they are stained by DNA dyes. Euchromatin stains 
lightly with DAPI (4’, 6-diamidino-2-phenylinodole), indicative of  “open” structure 
and accessible to transcription factors. It includes mostly transcriptional active 
regions that are rich in genes and regulatory sequences(Grewal and Elgin, 2002).  
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On the contrast, inactive gene-poor regions are packaged into highly condensed 
heterochromatin that are stained more intense with DAPI than the euchromatic 
segments(Grewal and Elgin, 2002). Heterochromatin is further classified into two 
types: constitutive heterochromatin and facultative heterochromatin. Constitutive 
heterochromatin contains centromeres and telomeres. They are silent in all cell 
types(Saksouk et al., 2015). Facultative heterochromatin is silenced in a cell-type 
specific manner(Johnson and Straight, 2017). Heterochromatin shows preferred 
clustering at the nuclear periphery, near the nucleoli or pericentromeric bodies 
(Politz et al., 2013; Padeken and Heun, 2014; Politz et al., 2016). The 
mechanisms which drive chromatin partition in the nucleus remain incomplete. 
1.3.1: Lamina Associated Domains 
In metazoans, the nucleoplasmic surface of the inner nuclear membrane 
is structurally supported by the nuclear lamina (NL), a filamentous meshwork 
consisting of filament proteins named lamins (Akhtar and Gasser, 2007).  NL acts 
as a surface for anchoring specific DNA sequences(Taddei et al., 2004). The 
regions contacting it are referred to as lamina associated domain (LADs). LADs 
have been identified by means of the DNA adenine methyltransferase 
identification followed by genome-wide sequencing (Dam ID)(Pickersgill et al., 
2006; Guelen et al., 2008; Peric-Hupkes et al., 2010). Briefly, fusion of nuclear 
lamina protein (typically Lamin B1) with bacteria DNA adenine methyltransferase 
(Dam) methylated genomic loci which are in close proximity to the fused nuclear 
lamina protein at nucleotide adenine(Steensel and Henikoff, 2000; van Steensel 
et al., 2001). Because eukaryotes lack adenine methylation, genome-scale 
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mapping of this orthologous mark reveals genomic loci that contact nuclear 
lamina.  
LADs are remarkably large genomic segments, ranging in size from 40 
kilobases to over 30 megabases(Pickersgill et al., 2006; Guelen et al., 2008; 
Peric-Hupkes et al., 2010).   In mouse and human cells, they covered ~40% of 
the genome. LADs are primarily heterochromatic AT rich regions(Pickersgill et al., 
2006; Guelen et al., 2008; Peric-Hupkes et al., 2010). Intuitively, LADs possess 
several molecular features typical of heterochromatin. For example, LADs have a 
low overall gene density and are enriched in repressive histone modifications 
H3K9me2 and H3K9me3 (Guelen et al., 2008; Wen et al., 2009). Although most 
genes in LADs are expressed at very low levels or transcriptional silent, LADs 
also contain some H3K4me3-marked chromatin that is presumably 
unrepressed(Guelen et al., 2008; Peric-Hupkes et al., 2010) , suggesting nuclear 
periphery position can function more than a repressive compartment.  
Understanding the organization of genomes require the identification of 
mechanisms that mediate this targeting. Various molecular mechanisms have 
been proposed to explain how endogenous loci become targeted to the periphery.  
First, repressive histone modifications have a prominent role in facilitating 
NL –LADs association(van Steensel and Belmont, 2017). In C. elegans and 
mammalian cells, disruption of methyltransferase mediated H3K9me3 deposition 
weaken the association between LADs and NL(Towbin et al., 2012; Bian et al., 
2013; Kind et al., 2013a; Chen et al., 2014; Harr et al., 2015). The repressive 
histone mark H3K27me3 is also linked to LADs.  Disruption of H3K27Me3 
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relocated a periphery located transgene array to the nuclear interior (Harr et al., 
2015). 
Second, there are specific protein factors that contribute to promote LADs 
to the nuclear periphery. NL proteins and proteins interacting with both NL 
proteins and chromatin components are important for peripheral tethering of 
heterochromatin(van Steensel and Belmont, 2017). For example, the interaction 
between Xist and Lamin B receptor anchors Xi to nuclear periphery (Chun-Kan 
Chen et al., 2016).  
Several studies have reported a correlation between transcription and 
nuclear periphery sequestration.  Artificial tethering experiments in which 
exogenous loci were fused with lamins showed reduction in expression upon 
peripheral relocalization(Reddy et al., 2008; Finlan et al., 2008). However, 
nuclear periphery reposition does not result in gene repression at every loci 
tested.  Some active genes near the tethering sites were present on 
chromosomes repositioned to the nuclear periphery(Finlan et al., 2008)indicating 
that transcription is compatible with nuclear periphery. Indeed, with a strong 
transcription activator, relocation of a reporter gene array to the nuclear lamina 
displays similar kinetics of reporter activation when it was positioned in the 
nuclear interior(Kumaran and Spector, 2008). NL harbors enzymatic activities 
such as histone deactylase HDAC3 that modify chromatin state(Somech et al., 
2005; Demmerle et al., 2012). During the in vitro differentiation of mESC to NPC, 
many genes with neural functions were released from the lamina. They were 
activated immediately or become “unlocked” from silent states that are more 
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likely to be activated later(Peric-Hupkes et al., 2010).Therefore, perinuclear 
localization appears to alter chromatin states rather than initiate transcriptional 
changes per se(Mattout et al., 2015).  
1.3.2: Nucleolus Associated Domain (NADs) 
Nucleoli are the largest non-membrane bound organelles within the 
nucleus. It is where rDNA transcription, rRNA processing and ribosome 
biogenesis occur. In human cells, nucleoli form around genomic regions called 
nucleolar organizing regions (NORs) located on the short arms of five acrocentric 
human chromosomes 13,14,15,21 and 22 (Sirri et al., 2008; Pederson, 2011).   
Nucleoli are surrounded by a subset of highly structured genomic 
elements  termed nucleolar associated DNA sequences(NADs) (Norton et al., 
2009; Koningsbruggen et al., 2010; Németh et al., 2010; Dillinger et al., 2016). 
Similar to LADs, NADs are large genomic regions with low gene density and 
enriched with multiple repressive histone marks. Satellite repeats and gene 
families including 5S rRNA, immunoglobulins, defensin (DEF), olfactory receptor 
(OR), and tRNA are enriched in the NADs(Norton et al., 2009; Koningsbruggen 
et al., 2010; Németh et al., 2010; Dillinger et al., 2016).  These gene families 
cluster as multigene arrays and are  expressed in a tissue specific manner. In 
female IMR-90 cell line, almost the entire Xi appeared as NADs (Dillinger et al., 
2016). Therefore, nucleolus sequestration maybe one means of transcriptional 
regulation during development.   
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1.4: NAD dynamics  
Repressive heterochromatin compartments change form and composition 
during development. So far, reorganization of NADs during differentiation has not 
been investigated in a genome-wide manner. One study compared NADs 
between human proliferating cells and senescent cells and revealed the 
extensive dissociation of centromeric and pericentromeric satellite repeats from 
nucleoli (Dillinger et al., 2016).  On the scale of each cell division, NADs must 
disassembly, replicate, undergo mitosis, and then reestablish in cycling cells.  
Below I will summarize the current understandings of three individual 
NADs loci during the cell cycle progression from single-cell studies. 
1.4.1: 1q12  
Three decades ago, the association of a pericentromeric region of 
chromosome 1 with the nucleolus was described in MCF-7 human breast cancer 
cells(Leger et al., 1994).  It was unexpected at that time because chromosome 1 
does not contain nucleolus organizer regions (NORs) (Sirri et al., 2008; Pederson, 
2011). Using Ki-67 staining patterns to distinguish stages of the cell cycle, cells 
display increased association from early G1 to mid S phase, where reaches the 
maximum and then decreases from mid S to G2. The number of nucleoli per cell, 
nor the fraction of the nuclear area occupied by nucleoli does not influence 1q12 
localization(Leger et al., 1994) .Notably, the nucleoli that associated with 1q12 
enlarged much more from S to G2 phase (Leger et al., 1994), indicating that it 
may provide a signal to promote nucleolar transcription activity. Sequencing 
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analysis of purified nucleoli from different cell lines reveals that 1q12 contain 
satellites repeats that are identified as NADs (Koningsbruggen et al., 2010; 
Németh et al., 2010). 
1.4.2:  Inactive X chromosome 
In Eutheria, males have one X chromosome and females have two X 
chromosomes. In order to achieve gene dosage balance between two sexes, 
females randomly inactivate one X chromosome. This process is called random 
X chromosome inactivation. X-inactivation is a preeminent example of facultative 
heterochromatin formation as it culminates in the transcriptional silencing of 
thousands of X-linked genes(Anguera et al., 2006).  
X inactivation initiates when XIST RNA is transcribed exclusively from a 
randomly selected X chromosome. Both the human XIST and mouse Xist genes 
lack an open reading frame, and produce long noncoding RNAs (IncRNA)(Brown 
et al., 1992; Brown et al., 1992).  During the initiation step of X chromosome 
inactivation, Lamin B Receptor (LBR) interacts with Xist to recruit Xi to the 
nuclear periphery and enable Xist to spread into actively transcribed genes along 
the chromosome (Chun-Kan Chen et al., 2016). Another preferred location of Xi 
is the nucleolar periphery(Barr and Bertram, 1949; Zhang et al., 2007; Dillinger et 
al., 2016). In MEFs, during mid-to-late S phase, Xi frequently visited nucleoli. In 
the rest of cell cycle or G0 phase, Xi rarely localized to the perinucleolar regions. 
Loss of perinucleolar localization in cycling cells results in erosion of several 
features of heterochromatin and reactivation of Xi at the single gene level(Zhang 
et al., 2007). 
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1.4.3: Kcnq1 
Kcnq1 region from placental is another example that associates with the 
nucleoli specifically during mid-late S phase. The lnc RNA Kcnq1ot1 silences 
imprinted genes in the lineage-specific manner(Pandey et al., 2008)(Mohammad 
et al., 2010). In the liver, Kcnq1ot1 silences ubiquitously imprinted genes next to 
the Kcnq1 domain.  In the placental, Kcnq1ot1 can repress both nearby 
ubiquitously imprinted genes and distal placental-specific imprinted genes(Lewis 
et al., 2004; Pandey et al., 2008; Mohammad et al., 2010). The imprinting of 
placental-specific imprinted genes is controlled by repressive histone 
modifications H3K27me3 and H3K9m3(Lewis et al., 2004; Pandey et al., 2008).  
In placenta cells, Kcnq1ot1 targets Kcnq locus to the nucleolus twice as 
frequently as observed in fetal liver cells during S phase(Pandey et al., 2008; 
Matheson and Kaufman, 2015).  Mouse Kcnq1ot1 RNA contains 890 bp silencing 
domain. When it inserts into an episomal plasmid, transcript from silence domain 
targets episomal plasmid to the nucleoli during mid S-phase, spread repressive 
histone modifications and silence flanking reporter genes(Mohammad et al., 
2008).  
1.5:  cis/ trans-acting factors involved in NADs organization 
To understand the functional implications of the nucleolar heterochromatin 
compartment, it is necessary to thoroughly understand the molecular 
mechanisms that drive NAD-nucleolus interactions. NADs are typically 10kb- 10 
Mb in size with a medium size of ~700 kb(Koningsbruggen et al., 2010; Németh 
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et al., 2010; Dillinger et al., 2016). The contact of kilobases of chromatin with the 
nucleolus suggests involvement of multivalent interactions. These interactions 
may be driven by primary DNA sequences, chromatin features of NADs and 
nucleolar targeting proteins/RNAs. 
1.5.1: DNA sequences that target genomic regions to the nucleolus 
It is like that the ability of NADs to interact with the nucleoli is at least in 
part encoded in the DNA sequences. In microscopy studies, active Pol III that 
contains Pol III transcribed tRNAs and 5S rDNA, forms distinct foci in the 
nucleolar periphery(Haeusler and Engelke, 2006). Recent sequencing analyses 
of purified nucleoli reveal that 5S rDNA is highly enriched in the 
NADs(Koningsbruggen et al., 2010; Németh et al., 2010; Dillinger et al., 2016).  A 
study shows that ectopic integration of 119bp 5S rDNA sequence into new 
genomic location can autonomously re-direct the host regions to the nucleolar 
periphery and results in transcriptional repression of reporter genes and 
endogenous genes proximal to integration sites. The extent of transcriptional 
repression is closely correlated with the frequency of nucleolus association 
(Fedoriw et al., 2012b).  5S rDNA is transcribed by RNA polymerase III and is 
required for ribosome assembly for cell growth(Haeusler and Engelke, 2006). It 
remains to understand how the actively transcribed 5S rDNA genes escape the 
repressive heterochromatic environment of nucleolus periphery.   
	   21	  
1.5.2: CTCF 
The CCCTC-binding factor (CTCF) is a sequence specific - DNA binding 
protein with between 55,000-65,000 sites of enrichment throughout the human 
genome (Merkenschlager and Nora, 2016). In immortalized human leukemia cell 
line, CTCF interacts with nucleolar protein nucleophosmin and tethers an 
exogenous insulator element to the nucleolus (Yusufzai et al., 2004). In female 
cell lines, CTCF depletion significantly relocalized Xi from the nucleolus(Yang et 
al., 2015). Because CTCF depletion reduces expression of Firre which is also 
required for perinucleloar localization of Xi(Yang et al., 2015), CTCF can regulate 
Xi perinucleolar localization through direct tethering and regulating Firre 
expression(Matheson and Kaufman, 2015).   
1.5.3: Histone modifications as anchoring signals 
As discussed above, in both C.elegans and mammalian cells, histone 
H3K9 methylations are implicated as anchoring signals for perinuclear 
chromatin(Towbin et al., 2012; Bian et al., 2013; Kind et al., 2013a; Chen et al., 
2014; Harr et al., 2015). NADs are also enriched in H3K9me3(Koningsbruggen et 
al., 2010; Németh et al., 2010; Dillinger et al., 2016).  In replicative senescent 
cells, most NADs-nucleolar associations are maintained but H3K9me3 enriched 
centromeric and pericentromeric repeats extensively dissociated from the 
nucleolus(Dillinger et al., 2016). Further analysis of NADs purified from cells 
depleted of the H3K9 methyl transferase Sedb1, Suv39 or G9a is needed.  
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1.5.4: lncRNAs for nucleolar targeting of inactive X chromosome  
 X-chromosome inactivation represents a powerful model system for 
facultative heterochromatin that associates with nucleoli. Close proximity of Xi to 
lamina or nucleolus may facilitate initiation and maintenance of heterochromatic 
features and transcriptional silencing. In MEFs, Xi frequently associates with 
nucleolus during mid-late S phase. Reduced perinucleolar targeting of the Xi 
results in several features of compromised heterochromatin including decreased 
H3K27me3 enrichment and Xi reactivation at the single gene level (Zhang et al., 
2007).  
Two lncRNAs have been identified tether Xi to the nucleolus. The first one 
is the Xist lncRNA which is essential for silencing and compaction of the X 
chromosomes.  The Xist gene is located in the 2.3 Mb region called the X 
inactivation center (XIC) (Chureau et al., 2002), which contains several 
noncoding genes that regulate XIST. In MEF, deletion of Xist from endogenous 
Xic loci significantly reduces Xi-nucleolar association. Conversely, autosomes 
carrying Xic transgenes preferentially associate with nucleoli and displayed S 
phase dependent association as the endogenous Xi did (Zhang et al., 2007; 
Kelsey et al., 2015). Chromatin context around the integration sites does not 
influence the Xi-nucleolus association. In human male HT1080 cells, ectopic Xist 
cDNA is integrated into different regions in autosomes and the active X 
chromosome. Upon XIST expression, all the integration sites show increased 
perinucleolar localization and silencing of a reporter gene(Kelsey et al., 2015).  
However, the recruitment of repressive histone modifications is strongly 
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influenced by the pre-existing epigenetic features of integration sites (Zhang et 
al., 2007; Kelsey et al., 2015)   
Another example is the IncRNA Firre.  Firre is a strictly nuclear lncRNA 
which escapes X-chromosome inactivation(Hacisuleyman et al., 2014; Yang et 
al., 2015). It forms expression foci on both X chromosomes before and after X-
chromosome inactivation(Yang et al., 2015). In the mouse fibroblast, the Firre 
locus on the Xi contacts the nucleolus.  Depletion of Firre RNA decreases 
perinucleolar localization of the Xi.  (Yang et al., 2015). Although H3K27me3 
declustered on the Xi in Firre depleted cells, there are minimal effects on gene 
silencing, consistent with the idea that multiple functionally overlapping factors 
affect Xi heterochromatin localization and gene silencing(Csankovszki et al., 
2001)(Yang et al., 2015).  Insulator protein CTCF binds Firre locus specifically on 
Xi. However, depletion of Firre does not change the CTCT occupancy (Yang et 
al., 2015). It implicates that Firre can target Xi to the nucleolus independent of 
CTCF. Firre interacts with nuclear matrix factor hnRNPU and facilitates trans-
chromosome interactions among Xi and other five genomic loci (Hacisuleyman et 
al., 2014). Further studies should explore whether these genomic foci are 
enriched to the nucleolar periphery as well.  
1.5.5: Comparison between LADs and NADs organization 
In Table 1.1, I summarized the similarities and differences between LAD 
and NAD organization. 
	   24	  
 
Table 1.1: Features of LADs and NADs organization 	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1.6: G1/S phase checkpoint 
Normal cell cycle progression through interphase and mitosis is regulated 
by coordinated activation of cell cycle proteins and checkpoint pathways. Proper 
activation and inactivation of cyclin dependent kinase (CDK) is essential to 
promote proper transition through the cell cycle, and checkpoints are the control 
mechanisms which ensure cells are qualified to progress through the next phase. 
Currently, there are three known checkpoints: the G1 checkpoint, G2/M 
checkpoint, and the spindle checkpoint.  The G1/S cell cycle check point controls 
the commitment of cells to transition through the G1 phase to enter into the DNA 
synthesis S phase.  Several distinct transcription factors regulate S phase entry. 
They interact and coordinate with each other to regulate the cell cycle 
progression. 
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1.6.1: E2F-Rb pathway 
E2F transcription factors E2F1, E2F2, and E2F3 and the Retinoblastoma 
tumor suppressor protein (pRB) pathway are one of the major drivers for the 
G1/S transition.  The canonical model for its regulation is simple. pRB is a 
chromatin associated protein. When in the hypophosphorylated state, pRB 
associates with E2F transcription factors to prevent expression of genes required 
for S phase. Hyper-phosphorylation of pRB releases E2Fs and thereby allows 
cell cycle progression(Dyson, 1998).   
Besides sequestrating E2F transcription factors, pRB directly binds to the 
promoter and recruits a number of co-repressors to silence transcription. 
Examples of the proteins associated with pRB included histone deacetylases 
(HDAC1, HDAC2), DNA methyl transferase (DNMT1), chromatin remodeling 
complex BRG1, histone methyl transferases Suv39h1 and Suv4-20h1/h2 (Talluri 
and Dick, 2012).  
pRB does not always imply transcription repression. Under certain 
conditions, E2F/pRB complexes could associate with transcriptionally 
coactivators.  One study showed that upon DNA damage, pRB forms 
transcriptional active complex with transcription factor E2F1 and drives 
expression of pro-apoptotic genes (Ianari et al., 2009).  It indicates that pRB 
mediated transcription is context dependent. More than 300 proteins had been 
reported to associate with pRB(Morris and Dyson, 2001; Talluri and Dick, 2012). 
Depending on the stimuli, pRB can either recruit co-repressors or co-activators to 
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the binding regions. But how the different cellular processes dictate pRB’s 
interactome is largely unknown. 
pRB can function beyond G1/S checkpoint. In hTERT-RPE1 cells, 
depletion of pRB increased incidence of lagging chromosomes and abnormal 
chromosome segregation due to cohesion defects(Manning et al., 2010). By 
direct binding methyltransferase Suv4-20h2(Gonzalo et al., 2005), pRB facilitates 
H3K9me3 and H4K20me3 establishment at centromeric 
heterochromatin(Manning et al., 2010). Depletion of pRB reduces H4K20me3 
and loading of cohesion complex on centromeric regions. (Manning et al., 2010; 
Manning et al., 2014)  
1.6.2: p21 
The major role of p21 in the G1 checkpoint lies in its ability to bind and 
inactivate cyclin A /CDK2, cyclin E/CDK2, and cyclin D/CDK4 complexes(Xiong 
et al., 1993; Labaer et al., 1997; Gartel and Radhakrishnan, 2005).   
p21 directly inhibits DNA synthesis by binding to PCNA, the sliding clamp 
required for processive DNA polymerase activity. In vitro, a competition between 
p21 and Pol δ or RFC for binding to central loop of PCNA efficiently inhibits Pol δ 
DNA replication (Waga and Stillman, 1998) 
The effect of p21 on CDK is stoichiometry regulated and does not always 
inactivate CDK. Low levels of p21 can activate the CDK4/6 complex and facilitate 
S phase entry. One study shows that S130 phosphorylation on p21 is central for 
CDK activation. In the low p21 setting, CDK7 phosphorylates S130.  When 
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phosphorylated, p21 associates with CDK4/6 and facilitates CDK4/6 activation by 
rendering T172 on CDK4/6 more accessible to CAK(Bisteau et al., 2013). 
As a universal CDK inhibitor, overexpression of p21 can potentially inhibit 
cyclin B1-CDK1 and cyclin A-CDK1/2 complex and arrest cells at G2/M 
transition(Baus et al., 2003).   
1.6.3: DREAM complex 
During the G0, G1/S and G2/M phases, the RB-like pocket proteins p130 
and p107, repressive E2F transcription factors E2F4 or E2F5, dimerization 
partner 1 (DP1), and five subunits of the multi-vulval class B (MuvB) complex 
regulate expression of cell cycle dependent genes through a common pathway.  
These factors form a large multi-protein complex termed DREAM complex 
(Sadasivam and DeCaprio, 2013; Guiley et al., 2015; Fischer et al., 2016). 
DREAM complex changes its components through cell cycle progression. 
In serum-starved and quiescent G0 cells, p107 is not detectable. DREAM 
complex contains p130, E2F4 and MuvB complex. Knockdown or mutation of 
p130 increased p107 expression and formed a p107 DREAM complex 
instead(Hurford et al., 1997; Litovchick et al., 2007; Sadasivam and DeCaprio, 
2013).  When p107 and p130 are simultaneous depleted, the MuvB core is 
unable to form a functional DREAM complex during quiescence and prematurely 
enters into the cell cycle(Litovchick et al., 2007). During S phase, MuvB 
dissociates from p130 and sequentially recruits BMYB and FOXM1 to late cell 
cycle promoters(Litovchick et al., 2007). Increased activity of BMYB-MuvB-FOX1 
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up-regulates mitotic gene expression and promotes mitosis(Sadasivam and 
DeCaprio, 2013).  
Expression of early cell cycle genes is co-regulated by E2F/Rb and 
DREAM complex(Fischer et al., 2016). In serum-starved cells, DERAM binds to 
the promoters of E2F targets(Litovchick et al., 2007). It recruits histone 
deacetylase HDAC1 and represses S phase-promoting transcripts(Rayman et al., 
2002).  Disruption of DREAM complex by co-depletion of p130 and p107 in 
quiescent cells leads to derepression of E2F-targeted genes and premature G1 
phase entry(Hurford et al., 1997). When cells enter the cell cycle, E2F-binding 
sites were less bound by DREAM and switched to E2F binding(Litovchick et al., 
2007)(Sadasivam and DeCaprio, 2013).   Transcription by active E2F 
transcription factors permits cell cycle gene expression and continuance of the 
cell cycle.  (Shawna Miles 2017, Sada-sivam and DeCaprio 2013)  
1.7: Concluding Remarks 
1.7.1:  Mechanisms for targeting genomic regions to the nucleolus  
Heterochromatin is concentrated in three intranuclear regions: the nuclear 
periphery, the perinucleolar space and in pericentromeric bodies(Politz et al., 
2013; Padeken and Heun, 2014). Although many LADs overlap with NADs 
sequences and in situ hybridization studies show that PCH can overlap with PH 
or PNH in many tissue types(Koningsbruggen et al., 2010; Kind et al., 2013a; 
Politz et al., 2016), some heterochromatic genomic regions, such as constitutive 
LADs (cLADs), preferential interact with NL(Meuleman et al., 2013).  Increased 
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NAD association with NL occurs upon nucleoli disruption(Ragoczy et al., 2014). 
Peripheral positioned HBB transgenes shift to the pericentromeric compartment 
upon depletion of periphery targeting regions (Bian et al., 2013).These results 
indicate that distribution across these different heterochromatin compartments is 
at least partly nonstochastic and involves specific targeting elements.  
As nuclear lamina protein Lamin B can form the contact points for 
LADs(Shimi et al., 2015), nucleolar proteins mediating NAD organization have 
been reported.  In the plant Arabidopsis thaliana, cells from nucleolin mutant 
(nuc1) plants showed altered nucleolar morphology. Deep sequencing of purified 
nucleoli in nuc1 cells revealed decreased nucleolar association of telomeric 
heterochromatin(Pontvianne et al., 2016). In addition, in the cells expressing 
LacI-nucleolin (NCL) or LacI-nucleophosmin (NPM), LacO-tagged transgenes 
was targeted to the nucleolar periphery(Caudron-Herger et al., 2015).However, 
not all the nucleolar proteins can target genomic loci  to the nucleolus. Fibrillarin 
is localized in the dense fibrillar components of nucleolus. Fibrillarin is an rRNA 
2’-O-methyltransferase and histone H2A glutamine methyltransferase(Reichow et 
al., 2007). In the LacI-Lac system, fibrillarin cannot promote translocation of 
LacO transgenes to nucleoli(Caudron-Herger et al., 2015). LacO array integrated 
proximal to the rDNA repeats on chromosome 13 frequently associates with 
nucleoli and can be visualized by LacI-GFP(Booth et al., 2014). In this system, 
unbiased RNAi screen can identify proteins required for NADs localization. One 
challeng is that many proteins regulate NAD-nucleolus association, even at the 
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level of individual NADs. Depletion of individual proteins on the relocation may be 
modest due to redundancy.  
Below, I suggest a step -wise NAD assembly model. First, similar types of 
NADs exhibit a high affinity to each other. Certain nucleolar protein/RNAs target 
NADs to the nucleolus via recognition of specific DNA sequences, chromatin 
features such as DNA methylation and histone modifications. Once in the 
nucleolus, association with nucleolar components such as Alu RNA, rDNA or 
proteins reduce the off-rate of the NADs from nucleolus and prolong its residence 
time. Some NADs have more “contacts points” with nucleolus and can interact 
with the nucleolus in most cell types, while the other NAD-nucleolus interactions 
occu in only certain cell types.   
1.7.2: The functional distinction and redundancy among three repressive 
heterochromatin compartments 
There is substantial overlap between the three heterochromatin 
compartments. m6A-Tracer technique to track the destination of parental LADs in 
the daughter cells reveals that some LADs that end up in the nuclear interior after 
mitosis become closely associated with nucleoli(Kind et al., 2013a).  Similarly, as 
a result of stochastic reshuffling following mitosis, mother NADs reposition in the 
nuclear periphery and thus become LADs in daughter cells(Koningsbruggen et 
al., 2010). Furthermore, disruption of nucleoli causes a shift of associated 
genomic loci toward NL without gene derepression, indicating these regions are 
functionally equivalent as repressive compartments(Ragoczy et al., 2014; Politz 
et al., 2016). 
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However, three repressive heterochromatin compartments are not 
identical. In addition to the probabilistic distribution of heterochromatin, specific 
tethering elements preferentially position certain genomic loci at particular 
heterochromatin compartment. To better define the functional distinction and 
redundancy of heterochromatin compartment, it is essential to identify the 
constitutive and facultative LADs/NADs and correspondent targeting 
mechanisms.   
1.7.3: S-phase dependent NAD-nucleolus association  
Because LADs or NADs are typically several megabase in size, their 
ability to move in a given cell is limited(Gibcus and Dekker, 2013).  In vivo 
tagging and tracking of dynamics of LAD-NL interactions in single cell shows that 
interphase LADs move within 1 μm from the NL. NL-contacting loci is rarely seen 
to move all the way to the nuclear interior. Even acidic–activating domain VP16 
can disrupt H3K9me3 on the LADs and dislodge them further away from the NL, 
most of LADs still moved over a short distance from NL and are not found in the 
interior(Kind et al., 2013a). With respect to cell cycle, chromatin mobility peaks in 
early G1 where it associates with organization elements and seeds 
heterochromatic compartment reorganization(Thomson et al., 2004). During 
other phases of cell cycle, large chromatin segments at the scale of megabase is 
considerably less dynamic(Gibcus and Dekker, 2013).  
NAD dynamics throughout the cell cycle has not been investigated in a 
genome-wide manner, but a microscopic study at a single cell level identified S 
phase dependent association between Xi and the nucleolus(Zhang et al., 2007). 
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This movement is intriguing considering constrained chromosome mobility 
throughout interphase. Within one cell cycle, interphase Xi moves to the 
nucleolus and then moves away from it.  lncRNA Firre and XIST are important in 
perinucleolar localization of Xi(Zhang et al., 2007; Yang et al., 2015). Progression 
of cells through replication is required for position LADs to the nuclear periphery.  
In the cells blocked at G1/S transition, the loci change their positions relative to 
NL(Shachar et al., 2016) compared with asynchronous cells. But how the NADs-
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Chapter II: Ki-67 affects heterochromatic characteristics 
of the inactive X chromosome 
2.1: Abstract 
Ki-67 maintains heterochromatin-associated repressive histone 
modification H3K9Me3 and promotes association of alpha-satellite to the 
nucleolus in HeLa cells. These results indicate its involvement in heterochromatin 
organization. In this chapter, I illustrate Ki-67 affects Xi-nucleolus association in 
cell-type-specific manner.  Acute depletion of Ki-67 altered S phase specific 
perinucleolar localization of Xi in hTERT-RPE1 cells but not in virally-transformed 
293T cells. Notably, in hTERT-RPE1 cells, upon Ki-67 depletion, Xi that were 
localized away from the nuclear lamina displayed several features of 
compromised heterochromatin, including increased Pol II association, 
transcription of repetitive DNA, and decreased H3K27me3 and H4K20me1 
labeling. In contrast, in 293T cells, these heterochromatic characteristics of the 
inactive X chromosome remained unchanged.  
2.2: Introduction 
Nucleoli, the site of rDNA transcription and ribosome assembly, are the 
largest nuclear body in the nucleus. Notably, nucleolar periphery houses a 
subset of the cellular heterochromatin, which shares many loci with (Dillinger et 
al., 2016) and is exchanging dynamically with lamina-associated heterochromatin 
regions(Kind et al., 2013a; Koningsbruggen et al., 2010; Ragoczy et al., 2014). 
	   35	  
The observation of only a specific subset of the genomes non-randomly 
associates with nucleoli raises the question whether there are trans-acting 
factors specifically targeting the genomic loci to the nucleolus.  
X inactivation in female mammals is a classic example of facultative 
heterochromatin formation. Xi is usually localized to either the nucleolar 
periphery or to the nuclear lamina(Barr and Bertram, 1949; Chun-Kan Chen et al., 
2016; Zhang et al., 2007). In MEFs, it frequently associates with nucleoli during 
the mid to late S phase(Zhang et al., 2007). Association of Xi with the nucleolus 
ensures heterochromatin maintenance and gene silencing, rendering Xi a well-
suited model to study the relationship of heterochromatin compartment and 
biological functions. Recently, studies have demonstrated that Ki-67 promotes 
movement of several repetitive genomic loci to the nucleolus. Thus, my goal was 
to test whether Ki-67 can promote association between Xi and the nucleolus as 
well.   
2.3: Results 
2.3.1: Depletion of Ki-67 decreases perinucleolar localization of the Xi in 
asynchronous hTERT-RPE1 cells but not in tumor-derived 293T cells 
Ki-67 protein is localized to the nucleolus in interphase cells, and also 
regulates the association of repetitive DNA with the nucleolar periphery (Booth et 
al., 2014; Matheson and Kaufman, 2015). A prominent example of 
heterochromatin association with nucleoli is the inactive X chromosome (Xi) in 
mammalian female cells (Zhang et al., 2007). The perinucleolar space is a 
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subset of the heterochromatic compartment; another frequent location for 
heterochromatin is at the nuclear periphery, adjacent to the nuclear lamina (Politz 
et al., 2016). Accordingly, the Xi is usually localized to one of these two preferred 
locations (Zhang et al., 2007), Because Ki-67 depletion reduces alpha satellite 
localization to the perinucleolar region, we hypothesized that it might also affect 
the interphase localization of the Xi. We first examined Xi localization in 
asynchronous hTERT-RPE1 cells, a diploid retinal pigment epithelial cell line 
immortalized by an hTERT transgene (Bodnar et al., 1998).  We used immuno-
RNA-FISH to detect Xi-associated lncRNA XIST and nucleolar protein fibrillarin. 
Indeed, Ki-67 depletion resulted in a partial but statistically significant reduction in 
Xi-nucleolar associations (Fig 2.1 A-D). This loss of nucleolar association was 
accompanied by an increase of similar magnitude in Xi-lamina associations. 
Similar results obtained with two distinct Ki-67 depletion reagents, one a 
synthetic siRNA and the other a cocktail of in vitro-diced dsRNAs non-
overlapping the siRNA target, both of which efficiently depleted steady-state Ki-
67 levels (Fig 2.5 G and Fig 2.6 G).  However, in virally-transformed 293T cells, 
we observed no significant alteration in Xi-nucleolar associations (Fig 2.1 E-H), 
measured either as the total number of allele association, or the number of 
alleles associated per cell. Thus, we conclude that effects of Ki-67 depletion on 




















Figure 2.1: Depletion of Ki-67 redistributes the Xi chromosome in 
asynchronous hTERT-RPE1 but not in 293T cells.  Scale bars, 10 µm. A. Fluorescence	   microscopy	   images	   of	   representative	   hTERT-­‐RPE1	   cells	   treated	  either	   with	   scramble	   control	   or	   Ki-­‐67-­‐targeted	   siRNAs	   as	   indicated.	   Cells	   were	  analyzed	   by	   RNA-­‐FISH	   to	   detect	   XIST	   RNA	   (green)	   marking	   the	   Xi,	   and	   by	  immunofluorescence	  with	  anti-­‐fibrillarin	  antibodies	  (red)	  to	  label	  nucleoli.	  DNA	  was	  stained	  with	  DAPI	  (blue).	  	  B. Quantification	   of	   XIST	   association	   frequencies	   from	  panel	  A	   experiments.	   XIST	  associations	  with	   the	   indicated	   locations	  were	   counted;	   “total	   nucleolar”	   indicates	  the	  sum	  of	  XIST	  signals	  that	  are	  exclusively	  nucleolar	  plus	  those	  that	  also	  are	  on	  the	  nuclear	   periphery.	   Three	   biological	   replicate	   experiments	   were	   performed	   with	  mean	   percentage	   association	   and	   SDs	   graphed.	   Total	   cells	   assayed	   =	   363	   for	   si-­‐scramble,	   376	   for	   siKi-­‐67.	   Holm-­‐Sidak	   corrected	   p-­‐values	   comparing	   si-­‐scramble	  and	  siKi-­‐67	  treatments	  are	  indicated,	  with	  p-­‐values	  <	  0.05	  in	  red.	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Figure	  2.1:	  Depletion	  of	  Ki67	  redistributes	  Xi	  chromosome	  within	  asynchronous	  hTERT-­‐




2.3.2: Altered Xi-nucleolus association dynamics in synchronized hTERT-
RPE1 cells upon Ki-67 depletion  
The Xi-nucleolar association is cell-cycle regulated, occurring most 
prevalently in S phase cells (Zhang et al., 2007). We therefore examined Xi 
localization in synchronized cells using immuno-RNA-FISH experiments in which 
the Xi-associated lncRNA XIST was detected at the same time as the nucleolar 
protein fibrillarin. Cells were blocked near the G1/S transition of the cell cycle 
with hydroxyurea (HU) for 15 hours (Figure 2.2 A) (Zhang et al., 2007), which 
provided efficient arrest.  Cells were then released into drug-free media and 
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pulse-labeled with the deoxynucleotide analog EdU at two-hour timepoints 
across an 8-10-hour time course (Fig 2.2). In control cells treated with the 
scrambled siRNA, EdU labeling was first detected at the 2 hour time point, and 
displayed a typical early S phase pattern consisting of many small foci(Dimitrova 
and Berezney, 2002). At later time points, the pulse of EdU labeled larger foci, 
indicative of mid-late S phase patterns. Upon Ki-67 depletion, we observed a 
delay in the initial detection of EdU incorporation of approximately 2 hours (Fig 
2.2 B). Notably, the Ki-67 depleted population also displayed a higher percentage 
of cells that did not incorporate EdU during the time course (Fig 2.2 C). Together, 
these data indicates that Ki-67 depletion affects S-phase in hTERT RPE-1 cells. 
Next, we examined how Xi localization was altered during the 
synchronized cell time course (Fig 2.2 D-G). Consistent with published data from 
mouse cells (Zhang et al., 2007), the frequency of Xi-nucleolar associations 
peaked in middle S-late S phase transition; this was true for the frequency of Xi 
associations that were exclusively at the nucleolus (Fig. 2.2D), and for the 
frequency of Xi chromosomes simultaneously associated with both the nucleolus 
and the lamina (Fig. 2.2E). These peaks occurred in both the control and Ki-67-
depleted populations, with the Xi-nucleolar interaction peaks delayed two hours 
in the latter case. The two-hour shift correlates with the delay in S phase entry in 
the Ki-67-depleted cells  (Fig 2.2). 
As suggested by the Xi localization data from asynchronous cells (Fig 2.2 
A-D), Xi associations with the nucleoli and lamina were inversely related, so that 
the peak of nucleolar associations (Fig 2.2 D-E) coincided with the lowest 
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frequencies of laminar associations (Fig2.2 F). We note that when the total Xi-
laminar association frequencies were counted by summing the exclusively 
laminar associations (Fig. 2.2 F) plus those also associated with nucleoli 
simultaneously (Fig 2.2. E), we observed little change during the experiment 
(Figure 2.2 G). Thus, the biggest changes during S phase are lamina-associated 
Xi becoming transiently also associated with nucleoli (e.g. compare Fig. 2.2E and 
2.2F). Together, these data indicated that cell cycle-regulated Xi-nucleolar 
associations are delayed in concert with S phase entry upon depletion of Ki-67 in 






Figure 2.2: Frequency of Xi-nucleolus association in synchronized hTERT-
RPE1 cells. Scale bars, 5 µm A. Schematic	   of	   assay.	   Cells	  were	   released	   from	  HU	   arrest	   for	   the	   indicated	   time	  periods,	   pulsed	   for	   20	   min	   with	   EdU,	   and	   analyzed	   by	   click	   chemistry	   for	   EdU	  incorporation	  and	  assayed	  for	  Xi-­‐nucleolus	  association.	  B. Representative	  cells	  from	  the	  indicated	  time	  points,	  showing	  EdU	  staining	  (green)	  to	   detect	   the	   progression	   of	   S	   phase.	   Total	   DNA	   is	   visualized	   with	   DAPI	   staining	  (blue).	  S	  phase	  cells	  were	  categorized	  into	  3	  sub-­‐stages	  based	  on	  the	  number,	  size,	  shape	  and	  distribution	  of	  fluorescent-­‐labeled	  replication	  foci.	  During	  early	  S	  phase,	  small	   and	   numerous	   replication	   foci	   were	   scattered	   in	   the	   nuclear	   interior,	   but	  excluded	   from	  nucleolus,	  nuclear	  periphery	  and	  other	  heterochromatic	  regions.	  At	  mid-­‐S	   phase,	   replication	   takes	   place	   at	   the	   nuclear	   periphery	   and	   perinucleolar	  regions.	   Late	   in	   S	   phase,	   there	   are	   several	   large	   foci	   throughout	   the	   nucleus	  (Dimitrova	  and	  Berezney,	  2002).	  	  C. Distributions	  of	  EdU	  morphologies	  during	  the	  time	  course.	  Percentages	  of	  early	  S	  phase,middle	   S	   phase	   and	   late	   S	   phase	   EdU	   staining	  morphologies	   were	   counted	  in	  >300	  total	  cells	  per	  time	  point.	  
	   42	  







	   43	  
Figure 2.2:Frequency of Xi-nucleolus association in synchronized hTERT-
RPE1 cells.	  Scale	  bars,	  5	  µm 
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2.3.3: Ki-67 depletion leads to heterochromatin erosion on internalized Xi in 
hTERT-RPE1 cells but not in 293T cells  
Ki-67 is required for the normal cellular localization of heterochromatin-
associated histone modifications (Sobecki et al., 2016), and for the interphase 
nucleolar association of heterochromatic loci (Booth et al., 2014; Matheson and 
Kaufman, 2017a). Because the inactive X (Xi) chromosome is a well-studied 
example of facultative heterochromatin that associates with the nucleoli of female 
mouse (Zhang et al., 2007) and human cells (Petersen et al., 1962; Barr and 
Bertram, 1949; Bourgeois et al.,1985) we tested whether Ki-67 affected 
characteristics of Xi heterochromatin. Indeed, Ki-67 depletion in hTERT-RPE1 
cells resulted in a subset of cells that displayed reduced staining intensity for 
antibodies recognizing H3K27me3 and H4K20me1, histone modifications that 
are enriched on the Xi (Lucchesi et al., 2005; Kohlmaier et al.,2004)(Fig2.3 A, C, 
E, G). H3K27me3 is generated by the Polycomb PRC2 complex and is a 
keystone of facultative heterochromatic silencing (Cao et al.,2002; Di Croce et al., 
2013; Simon et al. 2013). H4K20me1 is generated by the PR-Set7/Set8/KMT5a 
enzyme (Beck et al., 2012) and together with H3K27me3 is an early mark on Xi 
chromosomes during the process of XIST-mediated inactivation (Kohlmaier et 
al.,2004,Beck et al., 2012). Notably, changes to either of these histone 
modifications were only observed in cells in which the Xi was localized away from 
the nuclear periphery (Fig. 2.3 B, D, F, H).  
Increased levels of repetitive element-rich Cot-1-hybridizing transcripts 
and RNA polymerase II have previously been observed in breast cancer cell lines 
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that display perturbations in Xi chromatin (Chaligné et al., 2015). We tested for 
changes in these properties in hTERT-RPE1 cells.  We detected an increase in 
the frequency of cells that display Cot-1-hybridizing transcripts or RNA 
polymerase II on the Xi upon Ki-67 depletion in hTERT-RPE1 cells (Figures 2.5-
2.6). As observed above for the histone modifications (Fig. 2.3), increased levels 
of Cot-1 RNA and Pol II within the XIST domain were only observed in cells in 
which the Xi was localized away from the nuclear periphery. Also, as for all other 
phenotypes detected, these changes were similar with either Ki-67 depletion 
reagents (Figs. 2.5-2.6). Changes in H3K27me3 and H4K20 me1 staining were 
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Figure 2.3: H3K27me3 and H4K20me1 staining of the inactive X 
chromosome were altered upon Ki-67 depletion in a subset of hTERT-RPE1 
cells. Scale bars, 5 µm. 
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Figure	   2.3:H3K27me3	   and	   H4K20me1	   staining	   of	   the	   inactive	   X	   chromosome	   were	  






















	   50	  
Figure	  2.4:	  H3K27me3	  and	  H4K20me1	  staining	  of	  the	  inactive	  X	  chromosome	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Figure	  2.4:	  H3K27me3	  and	  H4K20me1	  staining	  of	  the	  inactive	  X	  chromosome	  
were	  unaltered	  upon	  Ki-­‐67	  depletion	  in	  293T	  cells.	  Scale	  bars,	  5µm. 
 
	   52	  
Figure 2.5: Analysis of Cot-1 and Pol II enrichment on Xi in siRNA-treated 
hTERT-RPE1 cells. Scale bars, 5 µm. 
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Figure	  2.5:	  Analysis	  of	  Cot-­‐1	  and	  Pol	  II	  enrichment	  on	  Xi	  in	  siRNA-­‐treated	  hTERT-­‐RPE1	  
cells.	  Scale	  bars,	  5	  µm.	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Figure	   2.6:	   	   Analysis	   of	   Cot-­‐1	   and	  Pol	   II	   enrichment	   on	  Xi	   in	   esiRNA-­‐treated	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Figure	   2.6:	   Analysis	   of	   Cot-­‐1	   and	   Pol	   II	   enrichment	   on	   Xi	   in	   esiRNA-­‐treated	  
hTERT-­‐RPE1	  cells.	  Scale	  bars,	  5	  μm.	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2.3.4:  Some aspects of Xi structure and function were resistant to Ki-67 
depletion.  
Not all aspects of Xi heterochromatin were sensitive to Ki-67 depletion. 
For example, Ki-67 depletion did not alter the overall appearance of the XIST 
“cloud” that covers the Xi (Fig. 2.7 A).  In addition, RT-PCR showed no significant 
down regulation of XIST transcript expression (Fig. 2.7 I).  Also, there was no 
evidence for Xi chromosome-wide deprepression of transcription, as shown in 
the analysis of X-linked gene expression (Fig. 2.7 B), or in the analysis of allele-
specific transcription of X-linked genes detected via analysis of known SNPs 
(Table 2.1). Furthermore, an additional mark associated with the Xi, the histone 
variant macroH2A, did not change in appearance upon depletion of Ki-67 (Fig. 
2.7C-H). Together, the Xi data indicate that acute depletion of Ki-67 alters 
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Figure	  2.7:	  Some	  aspects	  of	  Xi	  structure	  and	  function	  were	  resistant	  to	  Ki-­‐67	  
depletion	  in	  hTERT-­‐RPE1	  cells.	  Scale	  bars,	  10	  μm.	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Figure	  	  2.7:	  Some	  aspects	  of	  Xi	  structure	  and	  function	  were	  resistant	  to	  Ki-­‐67	  depletion	  in	  hTERT-­‐RPE1	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Table	  2.1:Analysis	  of	  X-­‐linked	  SNP	  in	  RNAseq	  data	  
seqnames start end Symbol Conclusion 
chrX 110675623 110675623 CHRDL1 No evidence 
of escape in 
siKi67 






chrX 54809928 54809928 MAGED2 No evidence 
of escape in 
siKi67 
chrX 20125252 20125252 EIF1AX biallelic 
expression 
chrX 1011404674 101140674 CENPI No evidence 
of escape in 
siKi67 
chrX 101552926 101552926 ARMCX1 No evidence 
of escape in 
siKi67 
chrX 24995899 24995899 POLA1 No evidence 
of escape in 
siKi67 
chrX 104193.108 104193108 FAM199X No evidence 
of escape in 
siKi67 
chrX 109543785 109543785 NXT2 No evidence 
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2.3.5: Ki-67 does not affect perinucleolar localization of Xi in asynchronous 
mouse cell culture 
We extend our investigation to the female mouse embryonic fibroblast cells. We 
performed immuno-RNA-FISH to detect Xi-associated lncRNA Xist and nucleolar 
protein fibrillarin. Asynchronous primary MEF transfected with a scramble control 
siRNA displayed ~45% of Xist alleles associate with nucleoli, which is consistent 
with previous report (Zhang et al., 2007).  Cells transfected with siRNA reagents 
directed against Ki-67 mouse RNA does not display altered Xi association 
frequencies with nucleoli (Fig 2.8 A-B). Efficient depletion of Ki-67 protein has 
been confirmed by the immunoblotting(Fig 2.8C).  It indicates that Ki-67 does not 












Figure 2.8: Depletion of Ki-67 does not redistribute the Xi within 
asynchronous primary MEF.  Scale bars, 10 µm. 
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A. Fluorescence microscopy images of representative primary MEF treated either 
with scramble control or Ki-67-targeted siRNAs as indicated. Cells were analyzed 
by RNA-FISH to detect XIST RNA (green) marking the Xi, and by 
immunofluorescence with anti-fibrillarin antibodies (red) to label nucleoli. DNA 






Figure 2.8: Depletion of Ki-67 does not redistribute the Xi chromosome 
within asynchronous primary MEF. Scale bars, 10 µm 
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2.4: Discussion 
2.4.1: Ki-67 contributes to the interphase localization of the Xi chromosome 
Nucleoli are non-membrane bound organelles within the nucleus. Not only 
are these sites of synthesis and assembly of ribosome components, the 
periphery of these organelles plays an important role in higher order 
chromosome localization (Politz et al., 2016; Chubb et al., 2002). Specifically, the 
nucleolar periphery houses a subset of the cellular heterochromatin, which is 
largely overlapping with (Dillinger et al., 2016) and exchanging dynamically with 
lamin-associated heterochromatin regions (Kind et al., 2013; Koningsbruggen et 
al., 2010; Ragoczy et al., 2014). Like other heterochromatin regions, high 
resolution analysis of nucleolus-associated domains (termed NADs) in human 
cells reveals enrichment of satellite repetitive DNAs and repressive histone 
marks (Koningsbruggen et al., 2010; Dillinger et al., 2016; Németh et al., 2010). 
Major questions in chromosome biology are how heterochromatin regions are 
partitioned to different intranuclear locations, and how these interactions are 
governed by cell cycle progression.  
As a region of facultative heterochromatin, the mammalian inactive X (Xi) 
chromosome in female cells is enriched in NAD loci, usually localized to either 
the nucleolar periphery or to the nuclear lamina ( Barr and Bertram, 1949; Zhang 
et al., 2007; Dillinger et al., 2016). In mouse cells, the Xi-nucleolar association is 
cell cycle-dependent, with frequencies peaking during mid-to-late S phase. A 
genetic deletion was used to show that the long non-coding RNA Xist, which is 
expressed from the Xi chromosome, is required for normal Xi-perinucleolar 
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localization. Deletion of Xist results in diminished H3K27me3 enrichment and 
increased synthesis of Cot-1-hybridizing, repeat-derived RNAs on the Xi (Zhang 
et al., 2007). These data suggest that perinucleolar localization of Xi contributes 
to the maintenance of heterochromatin structure. More recently, depletion of long 
non-coding RNA Firre was shown to reduce association of the Xi to nucleolus, 
and also reduces H3K27me3 density on the Xi (Yang et al., 2015). However, 
Firre depletion has minimal effects on Xi gene silencing, consistent with the idea 
that multiple functionally overlapping factors affect Xi heterochromatin 
localization and gene silencing. 
Here, we discovered that Ki-67 affects the Xi-nucleolus interaction. 
Analysis of synchronized RPE-1 cells shows that the association appears more 
slowly in Ki-67-depleted cells, coincident with the delay in S phase entry. In 
addition to this delay, Ki-67 depletion alters some of the heterochromatin 
characteristics of the Xi, causing significantly increased levels of Cot-1-
hybridizing RNAs and Pol ll, and decreased enrichment of H3K27me3. This loss 
of heterochromatic properties is partial in the cell population, and we do not 
detect uniform reactivation of Pol II genes on the Xi (Table 2.1). These data are 
consistent with previous studies showing that multiple overlapping mechanisms 
maintain the inactive status of the Xi (Csankovszki et al., 2001; Yang et al., 2015). 
We note that XIST levels are not reduced upon Ki-67 depletion (Fig 2.7 I), 
suggesting that altered XIST levels are unlikely to explain the effect of Ki-67 on 
the Xi. Instead, our data is consistent with the view that Ki-67 is one of the factors 
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that contributes to the maintenance of heterochromatic structures of the Xi 
(Sobecki et al., 2016) in this case in a manner coupled to S phase progression.   
Recent data show that the nuclear lamina localization mediated by the 
interaction between XIST and the lamina B receptor facilitates the spreading of 
XIST on the Xi chromosome, which in turn contributes to transcriptional silencing 
(Chun-Kan Chen et al., 2016). This raises the question of whether there are 
specific protein factors that contribute to the association of the Xi with the 
nucleolus in addition to the lncRNAs XIST and FIRRE (Zhang et al., 2007; Yang 
et al., 2015). Could Ki-67 be such a factor? One possibility consistent with our 
data is that Ki-67’s primary role in Xi localization being related to S phase 
progression, which favors the Xi-nucleolar association via unknown mechanisms. 
However, one aspect of Ki-67 function here may not solely result from cell cycle 
progression regulation. It appears that the erosion of heterochromatic features on 
the Xi occurs in a significant fraction of Ki-67-depleted cells away from the 
nuclear lamina, but the lamin-associated Xi chromosomes are not altered. There 
are two possibilities to explain these data. First, it may be that lamina association 
confers protection from heterochromatin changes. Alternatively, those Xi 
chromosome that experience altered structures upon Ki-67 may preferentially 
relocalize away from the lamina. Because our shRNA-based experiments 
necessitate a 72-hour period to achieve strong Ki-67 depletion, there is likely 
passage through multiple mitoses for each cell during this period. As Ki-67 is a 
key component of the perichromosomal layer that envelopes each mitotic 
chromosome (Booth et al., 2014; Cuylen et al., 2016), it is tempting to speculate 
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that the loss of Ki-67 affects the reassociation of heterochromatic sequences with 
the nuclear lamina or nucleoli after mitotic exit.  
2.5: Materials and methods 
2.5.1: cell culture methods 
hTERT-RPE1 cells (a kind gift from Dr. Judith Sharp) was cultured in 
DMEM-F12 medium (VWR 12001-600) with 10% fetal bovine serum (FBS, 
Hyclone #SH30910.03), 1% penicillin/streptomycin, 5% L-glutamine and 7.5% 
sodium bicarbonate solution.  
293T cells were cultured in DMEM medium with 10% FBS, 1% 
penicillin/streptomycin, 5% L-glutamine. The cells were split 1:4 every 3 days 
Primary MEF were cultured in DMEM medium with 10% FBS, 1% 
penicillin/streptomycin, 5% L-glutamine. The cells were split 1:3 every 2 days 
For hydroxyurea treatment, hTERT-RPE1 cells were cultured in the 
presence of 2 mM hydroxyurea for 15 h, then washed with three times 
phosphate-buffered saline (PBS) and released into hydroxyurea-free medium 
and harvested at the indicated time points. 
2.5.2: Immunofluorescence 
Cells grown on glass coverslips were fixed in 4% paraformaldehyde for 10 
min and then permeabilized with 0.5% Triton X-100 for 10 min at room 
temperature. The fixed cells were blocked in 5 % goat serum for 30 min, and 
incubated in primary antibody at 37 OC in a humidified chamber for 1h.  The cells 
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were washed with PBS for 5 min three times, incubated with secondary antibody 
for 1 h at 37 OC in humidified chamber, followed by three PBS washes, 5 min 
each. Slides were then incubated with 130 ng/ml 4,6-diamidino-2-phenylindole 
(DAPI) for 5 min and mounted in Vectashield mounting medium (Vector Lab, H-
1000) 
Images were taken on a Zeiss Axioplan2 microscope with a 63× objective. 
Entire cells were imaged using 200 nm step-intervals and displayed as maximum 
intensity projections generated using AxioVision version 4.6.  
The Xi-nucleolar association frequencies were scored in a blinded manner. 
Densitometry of individual immunostained cells was performed in Image J 10.2 
macro script. 
2.5.3: Immuno-RNA-FISH and RNA-FISH 
The plasmid pGIA which contains human XIST exons 4, 5 and 6 was a gift 
from Dr Judith Sharp. Cot-1 probe was from Invitrogen (Sigma 11581074001). 
The probes were labeled either with biotin-14-dCTP or digoxigenin-11-dUTP 
using the BioPrime DNA labeling system (Invitrogen 18094-011).  
For immunofluorescence (IF) combined with RNA-FISH, IF was performed 
first as above. Cells were then re-fixed in 4% paraformaldehyde for 10 min at 
room temperature. The cells were then dehydrated in 75%, 85%, 95% and 100% 
ethanol for 2 min each. Approximately 150 ng of each probe was mixed with 20 μg single-stranded salmon sperm DNA (Sigma-Aldrich) and 12 μg E. coli tRNA 
and then air-dried in a speed vacuum, resuspended in 20 ml 50% formamide / 50% 
hybridization buffer (20% Dextran Sulfate in 4× SSC), denatured at 80 OC for 10 
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min and pre-annealed at 37 OC for 30 min prior to hybridization. Hybridizations 
were performed overnight in a humidified chamber at 37OC. The next day, cells 
were washed for 20 min in 50% formamide in 2× SSC at 37°C and then for 20 
min in 2× SSC at 37°C and 20 min in 1× SSC at 37°C. The hybridized probes 
were detected by incubation with either Alexa fluor-488 conjugated to streptavidin 
(Invitrogen S-32354) or Dylight 594 labeled anti-Digoxigenin/Digoxin (Vector 
Labs, DI-7594) at 1:500 dilutions for 60 min in a 37OC humid chamber. After 
incubation, slides were washed twice in 50% formamide, 2× SSC for 5 min and 
once in 1× SSC for 5 min in a 37OC humid chamber before DAPI staining as 
above.  
2.5.4: siRNA 
The siRNA targeting human Ki-67 is from the collection of Silencer Select 
Predesigned siRNAs (Thermo Fisher Scientific), and targets nucleotides 559-577 
of the cDNA (NM_002417.4). 
Its sequence is as follows:  
sense CGUCGUGUCUCAAGAUCUAtt,  
antisense UAGAUCUUGAGACACGACGtg 
2.5.5. esiRNA methods 
esiRNAs were generated using the DEQOR method (Surendranath et al., 
2013), with primers designed using the DEQOR database (http://deqor.mpi-
cbg.de/deqor_new/input.html) to generate T7-tailed dsDNA templates from 
human cDNA in two rounds of PCR. RNA from hTERT-RPE1 cell line was used 
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to generate cDNA. In the 1st round of PCR, primers specific to the gene of 
interest (Luciferase, or Ki-67) were used in the following program: 95 °C for 3 
mins, 16 cycles of (95 °C for 1 min, 65 °C -1 °C/cycle for 1 min, and 72 °C for 1 
min) followed by an additional 15 cycles of (95 °C for 1 min, 60 °C for 1 min, and 
72 °C for 1 min) and one final cycle at 72 °C for 5 mins. In the 2nd round of PCR, 
a T7 promoter-tailed primer was used to amplify the product of the 1st round with 
the following program: 95 °C for 2 mins, 4 cycles of (95 °C for 30 seconds, 42 °C 
for 45 seconds, and 72 °C for 1 min) followed by an additional 29 cycles of (95 °C 
for 30 seconds, 60 °C for 45 seconds, and 72 °C for 1 min) and one final cycle at 
72 °C for 5 mins.  The product of the 2nd round of PCR is used to transcribe ds 
esiRNA using T7 RNAP in presence of 25 mM NTPs and 40 mM Tris pH 7.9, 6 
mM MgCl2, 2 mM spermidine and 10 mM NaCl using the following thermocycler 
program: 37 °C for 5 hours 30 mins, 90 °C for 3 mins, Ramp 0.1 °C/second to 
70 °C, 70 °C for 3 mins, Ramp 0.1 °C/second to 50 °C, 50 °C for 3 mins, Ramp 
0.1 °C/second to 25 °C, 25 °C for 3 mins.  After transcription and annealing, 
products were digested with 2U of RQ1 DNAseI for 15 minutes at 37 °C. 
esiRNAs were then generated by digesting dsRNAs with RNAse III (Fazzio et al., 
2008) and purified as described using Invitrogen RNA Mini Kits.  
esiRNA targets Ki-67 repeat regions at nucleotides 3611-4047, 3979-4357, 
4705-5098 and 6913-7347 of the cDNA (NM_002417.4). 
Forward primer for hKi-67  
gcgtaatacgactcactataggGTGCTGCCGGTTAAGTTCTCT 
Reverse primer for hKi-67 
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gcgtaatacgactcactataggGCTCCAACAAGCACAAAGCAA 
Forward primer for luciferase  
gcgtaatacgactcactataggAACAATTGCTTTTACAGATGC 
Reverse primer for luciferase 
gcgtaatacgactcactataggAGGCAGACCAGTAGATCC 
Cells were transfected with Lipofectamine RNAi MAX (Invitrogen Catalog 
number 13778100) following manufacturer’s instructions.  
For esiRNA transfection, 500ng of esiRNA targeting either luciferase 
control or Ki67 was transfected into 40 × 103 cells. 
For siRNA transfection, 40 nM of either scramble or siKi67 was 
transfected into 40 × 103 cells. 
The cells were harvested 72 hrs after transfection for immunoblotting, RT-
qPCR, RNA-seq, FACS or FISH analysis.  
2.5.6. Visualization of 5-ethynyl-2-deoxyuridine(EdU)-labeled nascent DNA  
hTERT-RPE1 cells were grown on glass coverslips in DMEM/F12 media 
as described above. 5-ethynyl-2-deoxyuridine (EdU) was added to the culture 
medium at concentration of 10 mM for 20 min. After labeling, cells were washed 
three times with PBS. Cells were then permeablized in 0.5% Triton X-100 for 30 
seconds and then fixed in 10% formaldehyde for 10 min.  Cells were then rinsed 
twice with PBS and then incubated 30 min in 100 mM Tris-HCl pH 8.5, 1 mM 
CuSO4 , 100 mM ascorbic acid plus 50 mM carboxyrhodamine 110-azide for 
click-chemistry labeling. After staining, the cells on coverslips were washed three 
times with PBS plus 0.5% Triton X-100, 5 min each. Cells were then 
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counterstained with DAPI, mounted in Vectashield and imaged by fluorescence 
microscopy as above.  
2.5.7: Immunoblotting 
For immunoblotting, cells were collected 3 days after RNAi transfection. 
Whole-cell lysates were extracted in 20 mM Tris-HCl 7.5, 1% SDS and 10% 
glycerol supplemented with protease inhibitor cocktail (Sigma P8340-1ml). The 
lysates were sonicated in a Bioruptor set on high power for one 5 min cycle, with 
30s on/30s off. 15 mg of each lysate were separated by SDS-PAGE, transferred 
to PVDF membrane and probed as described in the figure legends. 
Table	  2.2:	  Antibodies	  used	  for	  immunofluorescence	  and	  western	  blotting	  





nce	  Dilution	  	  
Wester
n	   Blot	  
Dilutio
n	  Fibrillarin	   Rabbit	   Abcam	   Ab5821	   1:500	   1:2000	  BrdU	   Mouse	   MoBu-­‐1	   Abcam	   ab8039	   0.5	  μg/106	  cells	   	  Ki-­‐67	   Rabbit	   Abcam	   Ab15580	   1:500	   1:2000	  beta-­‐tubulin	   Mouse	  	   Ubpbio	   Y1060	   	   1:10,000	  Amersham	   ECL	  Rabbit	   IgG,	   HRP-­‐linked	  whole	  Ab	   Rabbit	   GELife	  science	   NA934	   	   1:5000	  IgG	   (H+L)	  Secondary	  Antibody,	   Alexa	  Fluor®	  594	  
Rabbit	   Life	  Techonologies	   A-­‐21207	   1:2000	   	  
Secondary	  Antibody,	   Alexa	  Fluor®	  488	  	   Rabbit	   Life	  Technologies	   A-­‐21206	   1:2000	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Streptavidin,	  Alexa	  Fluor®	  488	  Conjugate	   	   Invitrogen	   S-­‐32354	   1:500	   	  DyLight	   594	  Labeled	   Anti-­‐Digoxigenin/Digoxin	  
	   Vector	  Labs	   DI-­‐7594	   1:500	   	  





















Chapter III: Ki-67 affects S phase gene expression and 
cell cycle progression in checkpoint proficient cells 
3.1: Abstract 
Although Ki-67 is widely used as a cell proliferation marker, whether it 
affects cell cycle progression has been controversial. I show here that depletion 
of Ki-67 in human hTERT-RPE1, WI-38, IMR90, and hTERT-BJ cell lines 
reduced the proportion of cells in S phase and coordinately downregulated genes 
related to DNA replication.  These cell lines are able to induce the expression of 
checkpoint protein p21. On the contrary, in tumor-derived U2OS, HeLa, and 
293T cells, I do not observed either the p21 induction or the alteration of the 
transcription and cell cycle distribution.  Further more, additional co-depletion of 
p21 thoroughly suppressed the transcriptional and cell cycle defects in diploid 
and primary cell lines.  Altogether, these results indicate that Ki-67 regulates cell 
cycle progression in p21 checkpoint proficient cells. 
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3.2: Introduction 
Ki-67 was first identified via an antibody raised against Hodgkin lymphoma 
cell nuclei (Gerdes et al., 1983).  Because Ki-67 is generally expressed strongly 
in proliferating cells and poorly in quiescent cells (Gerdes et al., 1984), anti-Ki-67 
antibodies are frequently used to detect proliferative cells in clinical 
studies(Gerdes et al., 1987; Dowsett et al., 2011). In interphase cells, Ki-67 
primarily localizes to the nucleolus(Verheijen et al., 1989a; Kill, 1996; Cheutin et 
al., 2003), whereas during mitosis, it coats the chromosomes(Verheijen et al., 
1989a; Saiwaki et al., 2005; Takagi et al., 2014). In the past few years, several 
studies have greatly increased our understanding of Ki-67 function. This is 
particularly true for its mitotic roles. Specifically, Ki-67 is required for formation of 
the mitotic perichromosomal layer(Booth et al., 2014)(Sobecki et al., 2016), a 
proteinaceous sheath that coats mitotic chromosomes(Van Hooser et al., 2005; 
Booth et al., 2016). As part of this layer, Ki-67’s large size and highly positively-
charged amino acid composition keeps individual mitotic chromosomes 
dispersed rather than aggregated upon nuclear envelope disassembly, thereby 
ensuring normal kinetics of anaphase progression (Cuylen et al., 2016). At	  anaphase	  onset, Ki-67 binds protein phosphatase 1γ (PP1γ)	  to form a holoenzyme 
(Kumar et al., 2016) important for targeting substrates that must be 
dephosphorylated during mitotic exit (Takagi et al., 2014). In contrast to its 
structural role on the mitotic chromosomal surface, Ki-67 does not appear to 
affect nucleosomal spacing (Cuylen et al., 2016) or condensation of individual 
mitotic chromosomes(Booth et al., 2016; Cuylen et al., 2016). 
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In addition to its expression in proliferating cells, other experiments 
suggested Ki-67 has a positive role in regulating cell proliferation. In early studies, 
antisense oligonucleotides targeting Ki-67 expression in human IM-9 multiple 
myeloma cells blocked [3H]-thymidine incorporation, indicative of inhibition of 
proliferation (Schluter et al., 1993). Likewise, Ki-67-targeted phosphorothioate 
anti-sense oligonucleotides that resulted in partial depletion of Ki-67 protein 
inhibited proliferation of human RT-4 bladder carcinoma and other tumor cell 
lines (Kausch et al., 2003). More recently, siRNA-mediated depletion of Ki-67 
resulted in reduced proliferation in human 786-0 renal carcinoma cells (Zheng et 
al., 2006).  
However, despite its utility as a proliferation marker, the contribution of Ki-
67 to cell proliferation has recently been questioned. For example, in one recent 
study, genetic disruption of Ki-67 in human MCF-10A epithelial breast and DLD-1 
colon cancer cells did not affect cell proliferation rates in bulk culture, although 
clonogenic growth of highly diluted cell populations was reduced (Cidado et al., 
2016). In another recent study, depletion of Ki-67 in human HeLa or U2OS cells 
did not alter cell cycle distribution (Sobecki et al., 2016).  These data raise the 
possibility that Ki-67 function may have different consequences in different cell 
types.   Experiments here investigated cell-type specific Ki-67’s involvement in 
cell cycle progression and molecular mechanism underlying the differences.  
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3.3:Results 
3.3.1: Acute depletion of Ki-67 affects S phase gene expression and S 
phase progression in hTERT-RPE1 cells 
To explore how Ki-67 impacts gene expression, we performed RNAseq 
analyses of hTERT-immortalized human diploid RPE1 cells depleted of Ki-67. Ki-
67 depletion resulted in both reduced and increased RNA levels at different loci 
(SRR4252548, SRR5535471, SRR5535778, and SRR5535934). However, 
Reactome pathway analysis of RNA abundance changes showed that the most 
altered functional sets of genes included those involved in DNA replication and 
cell cycle progression (Figure 3.1 A). For example, levels of RNAs encoding all 
subunits of several protein complexes involved in S phase progression were 
concertedly reduced, including DNA replication clamp loader RFC (RFC1-5 
genes), ssDNA-binding complex RPA (RPA1-3), the replicative helicase (MCM1-
6), the GINS replication initiation complex (GINS1-4), the DNA polymerase 
alpha/primase complex, as well as the DNA replication clamp PCNA and the flap-
endonuclease FEN1 involved in Okazaki fragment maturation. We confirmed 
reduced levels of a subset of replication-related RNA targets by RT-qPCR 
analyses (Figure 3.2A). Notably, the RT-qPCR data were very similar when 
obtained with two distinct Ki-67 depletion reagents, one a synthetic siRNA and 
the other a cocktail of in vitro-diced dsRNAs non-overlapping the siRNA target, 
both of which efficiently depleted steady-state Ki67 levels (Figures 3.2 A, B, I, J).  
We also observed that fluorescence-activated cell sorting (FACS) analysis 
of Br-dUTP-labeled cells showed that the proportion of S phase cells decreased 
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upon depletion of Ki-67 in hTERT-RPE1 cells with either depletion reagent 
(Figure 3.2 C-D; quantified in Fig. 3.2 E, G).  In contrast, proportions of G1 and 
G2/M populations were not significantly altered (Fig. 3.2F and 3.2 H). Therefore, 
Ki-67 is important for normal S phase distribution and gene expression in 
hTERT-RPE1 cells.  
As an additional control for the direct effect of the siRNA treatment, we 
used CRISPR/Cas9 to mutate the siRNA target site in hTERT-RPE1 cells (Fig. 
3.3 A-B). In a resulting homozygous mutant cell line (Figure 3.3 C), siKi-67 no 
longer depleted Ki-67 protein levels, but as expected the esiKi-67 reagent was 
still effective (Figure 3.3 D). We also observed that siKi-67 no longer altered 
candidate S phase RNA levels in the resistant cell line, but esiKi-67 did (Figure 
3.3E). We conclude that the transcriptional response to acute depletion of the Ki-
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Figure 3.2: Ki-67 depletion in hTERT-RPE1 cells reduced S-phase-related 
mRNA abundance and the proportion of cells in S phase. 
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Figure	   	   3.2:	   Ki-­‐67	   depletion	   in	   hTERT-­‐RPE1	   cells	   reduced	   S-­‐phase	   related	   mRNA	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Figure 3.3: Validation of specificity and effectiveness of Ki-67 depletion 
reagents. 
 
 A. 	  CRISPR/Cas9-­‐based	   strategy	   for	   generating	   siRNA-­‐resistant	   mutations	   in	   the	  endogenous	   Ki-­‐67	   gene.	   The	   si-­‐Ki-­‐67	   target	   (green)	   and	   sgRNA-­‐directed	  cleavage	   site	   (red	   triangle)	   are	   indicated	   on	   the	   upper	   diagram	   of	   the	  endogenous	  locus.	  Altered	  nucleotides	  (red)	  and	  the	  novel	  EcoO109I	  restriction	  site	  are	  shown	  on	  the	  lower	  diagram	  of	  the	  repair	  template.	  B. DNA	  sequence	  analysis	  of	  a	  PCR	  product	  from	  wild-­‐type	  hTERT-­‐RPE1	  cells	  and	  si-­‐Ki-­‐67-­‐resistant	  clone	  #7.	  C. EcoO109I	  digestion	  of	  the	  same	  PCR	  product	  sequenced	  in	  panel	  B.	  	  D. Immunoblot	  analysis	  of	  clone	  #7	  treated	  with	  the	  indicated	  reagents.	  E. RT-­‐qPCR	  analysis	  of	  clone	  #7.	  	  
F-L. Immunoblot analyses of the indicated cell lines, treated with the indicated 
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3.3.2:  Acute depletion of Ki-67 affects S phase gene transcription and the 
proportion of cells in S phase in diploid fibroblasts and primary cells, but 
not in tumor derived cell lines. 
Recent studies challenge the view that Ki-67 is important for human cell 
proliferation; for example, depletion of Ki-67 had minimal effects on the cell cycle 
distribution of tumor-derived HeLa or U2OS cells (Sobecki et al., 2016). Because 
our data indicated that Ki-67 contributes to normal cell cycle progression in 
hTERT-RPE1 cells, we hypothesized that the contribution of Ki-67 to cell cycle 
progression would be cell type-dependent, and may be related to checkpoint 
function. To explore this idea, we depleted Ki-67 in several additional cell lines. 
We compared diploid, non-immortal WI-38 and IMR90 fibroblasts, hTERT-
immortalized BJ fibroblasts, and primary human foreskin fibroblasts (HFFs) with 
tumor-derived cell lines: virally-transformed kidney (293T) or cervical carcinoma 
(HeLa) cells, and osteosarcoma U2OS cells. Importantly, we confirmed that all 
these cells could be efficiently depleted of Ki-67 protein using both of our 
depletion reagents (Figure 3.3 F-L).  
In all of the experiments with the non-tumor-derived cells, we observed 
reduced replication factor RNA levels and fewer cells in S phase, similar to our 
results in hTERT-RPE1 cells, and these results were independent of which Ki-67 
depletion reagent was used (Figures 3.4-3.5). In contrast, in the tumor-derived 
cell lines, Ki-67 depletion did not result in uniform down regulation of the S phase 
genes tested, nor were there changes in cell cycle distribution (Figures 3.6-3.7). 
These data are consistent with RNAseq data sets in HeLa and U2OS cells 
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(Sobecki et al., 2016) that did not display concerted downregulation of DNA 
replication genes. We conclude that the effects of Ki-67 depletion on RNA levels 
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Figure 3.4:  siRNA-mediated Ki-67 depletion affected S-phase gene 
expression and cell cycle distribution in diploid human cells.  
 
WI-38 (panels A-D), IMR-90 (panels E-H), hTERT-BJ (panels I-L) cell lines and 
human primary fibroblasts (HFF, panels M-P) were analyzed. A,	  E,	  I,	  M.	  	  	  RT-­‐qPCR	  analysis,	  as	  in	  Figure	  1E.	  B,	  F,	  J,	  N.	  	  	  FACS	  analysis,	  as	  in	  Figure	  1G.	  C,	  G,	  K,	  O.	  	  	  Quantification	  of	  percentage	  of	  S-­‐phase	  cells,	  as	  in	  Figure	  1I.	  





Figure	   1	   3.4:	   siRNA-­‐mediated	   Ki-­‐67	   depletion	   affected	   S-­‐phase	   gene	   expression	   and	   cell	   cycle	  
distribution	  in	  diploid	  human	  cells	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Figure	  2	  3.5:	  esiRNA-­‐mediated	  depletion	  of	  Ki-­‐67	  in	  diploid	  cells	  resulted	  in	  the	  same	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Figure 3.6: Ki-67 depletion did not affect S-phase gene expression and cell 
cycle distribution in HeLa (panels A-D), U2OS (panels E-H), and 293T 
(panels I-L) cell lines.  
 
Panels A, E, I:  RT-qPCR analysis. Panels B, F, J:  FACS analysis. Panels C, G, 
K:  Quantification of percentage of S-phase cells.  Panels D, H, L: Quantification 
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Figure	   3.6:	   Ki-­‐67	   depletion	   did	   not	   affect	   S-­‐phase	   gene	   expression	   and	   cell	   cycle	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Figure	  3.7:	  esiRNA-­‐mediated	  depletion	  of	  Ki-­‐67	  in	  insensitive-­‐cells	  resulted	  in	  the	  same	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3.3.3: Rb partially contributes to transcriptional down regulation caused by 
Ki-67 depletion  
Because Ki-67 depletion did not affect S phase transcription or cell cycle 
progression in tumor-derived cell lines, our data suggested that functional 
checkpoints are required for sensitivity to Ki-67 depletion.  Consistent with this 
idea were comparisons of our RNAseq data with metadata analyses of genes 
regulated by cell cycle status or by E2F transcription factors (Fischer et al., 2016) 
that are important for G1/S cell cycle phase transcription(Fischer et al., 2016; 
Sadasivam and DeCaprio, 2013; Bertoli et al., 2013). These meta-analyses 
aggregated multiple datasets, finding that coherent patterns of regulation in 
multiple datasets strongly predicted regulatory network connections that could be 
missed in single experiments. Of the cell cycle-regulated genes identified in that 
study, we find those that peak during G1/S phase were more frequently 
downregulated than upregulated upon Ki-67 depletion (Fig. 3.8 A). Consistent 
with this observation, E2F target RNA levels (Fig. 3.8 B) were much more 
frequently downregulated than upregulated upon Ki-67 depletion. These 
comparisons were consistent with the idea that checkpoint activation contributed 
to the observed delay in S phase entry and transcriptional phenotypes in Ki-67-
depleted cells. 
To test this, we performed experiments co-depleting checkpoint proteins. 
First, we took advantage of a derivative of hTERT-RPE1 cells that have an 
integrated, doxycycline-inducible shRNA that targets the RB mRNA (Manning et 
al., 2014). Rb levels remained unchanged in these cells in the absence of 
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doxycycline (Fig. 3.8 C), and siRNA-mediated depletion of Ki-67 resulted in 
reduced S phase-related RNA levels as was observed previously (Fig. 3.8D). 
Addition of doxycycline to deplete Rb, together with a control scrambled siRNA 
leaving Ki-67 levels unchanged, did not significantly alter S-phase related target 
RNA levels (Fig. 3.8D). In contrast, simultaneous depletion of Rb and Ki-67 
resulted in RNA levels at two of the four loci tested that were significantly 
elevated compared to those in cells depleted of Ki-67 alone (Fig. 3.8D). FACS 
analysis indicated that Rb depletion was insufficient to significantly change the 
cell cycle profile of Ki-67-depleted cells (Fig. 3.8E-F). We conclude that depletion 
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Figure	  3.8:	  Rb	  contributes	  to	  transcriptional	  downregulation	  caused	  by	  Ki-­‐67	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Figure	   	   3.8:	   Rb	   contributes	   to	   transcriptional	   downregulation	   caused	   by	   Ki-­‐67	  
depletion	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3.3.4: Co-depletion of p21 suppresses transcriptional and cell cycle 
progression responses to Ki-67 depletion 
As depletion of Rb only partially relieves the cellular response to Ki-67 
depletion in hTERT-RPE1 cells, we reasoned other factors must contribute. One 
clue was provided by comparison of the si-Ki-67 RNAseq data to metadata 
analysis of binding by subunits of the DREAM complex transcription repressor 
(Fischer et al., 2016). We observed that genes with the highest predicted 
probability of DREAM binding were very frequently downregulated upon Ki-67 
depletion (Fig. 3.8G). In mammalian cells, DREAM is a master regulator of cell 
cycle-dependent gene expression, repressing both G1/S and G2/M targets, and 
gene repression by DREAM requires the p21 checkpoint protein(Sadasivam and 
DeCaprio, 2013; Litovchick et al., 2007; Schmit et al., 2007). p21 is a potent 
universal CDK inhibitor (CKI). During G1 and S phases, it directly binds to and 
inhibits the kinase activity of cyclin E-CDK2, cyclin B1-CDK1 and cyclin D-
CDK4/6 complexes (Xiong et al., 1993; Gartel et al., 2005; Labaer et al., 1997). 
Furthermore, p21 also directly inhibits DNA synthesis by binding to PCNA, the 
sliding clamp required for processive DNA polymerase activity (Waga and 
Stillman, 1998). Therefore we hypothesized that p21 could be important for the 
response to Ki-67 depletion (Fig 3.10). 
Consequently, we next tested effects of Ki-67 depletion on the CDKN1A 
gene, which encodes p21. Our RNAseq data indicated increased CDKN1A RNA 
levels in Ki-67 depleted hTERT-RPE1 cells (log2 fold change = +0.48, p = 0.016), 
although multiple hypothesis testing indicated that these values did not achieve 
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the stringent statistical significance cutoff of q < 0.05. RT-PCR measurements of 
CDKN1A RNA levels demonstrated a significant increase in four diploid cell types, 
but not in 293T cells (Fig. 3.9A). We note that induction of CDKN1A RNA was 
dependent on having an intact siRNA target site in the Ki-67 gene, indicating this 
is a direct effect of Ki-67 depletion (Figure 3.3E). Consistent with the increased 
RNA levels, we detected elevated p21 protein levels in hTERT-RPE1 but not 
293T cells (Fig. 3.9B).  
p21 is a direct target of transcriptional induction by the tumor suppressor 
p53, and the cell lines examined thus far therefore implicated active p53 in the 
sensitivity to Ki-67  (El-Deiry et al., 1993; Deng et al., 1995). To examine this 
relationship further, we compared the effects of Ki-67 depletion in additional 
cancer cell lines, including two expressing wild-type p53, MCF7 and HCT116, 
and also MDA-MB-231 cells which express a mutant p53 defective for p21 
induction (Junk et al., 2008).  In MCF7 breast adenocarcinoma cells, we 
observed that Ki-67 depletion elevated p21 RNA and protein levels (Fig. 3.9 G,H), 
and down-regulated replication-related RNAs (Fig. 3.9H).  In contrast, in HCT116 
colorectal carcinoma and MDA-MB-231 breast adenocarcinoma cells, Ki-67 
depletion did not increase p21 expression or cause concerted down-regulation of 
S phase genes. (Fig. 3.9 G, I, J). Because HCT116 and MDA-MB-231 cells differ 
in their p53 status, we conclude that p53 status cannot always predict the 
response to Ki-67 depletion. Instead, we find that induction of p21 upon Ki-67 
depletion is a consistent hallmark of this form of checkpoint activation.  
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To assess the functional consequence of p21 induction, we performed co-
depletion experiments in hTERT-RPE1 cells (Fig. 3.9D). We observed that cells 
simultaneously depleted of both Ki-67 and p21 no longer displayed the reduced 
levels of any of the four S phase-related mRNAs analyzed (Fig. 3.9D). 
Furthermore, FACS analysis of the co-depleted cells showed that there was 
significant restoration of the percentage of cells in S phase upon codepletion of 
p21 with Ki-67 (Fig. 3.9E-F). We conclude that induction of p21 is functionally 
important for the effects of Ki-67 depletion on cell cycle distribution in hTERT-
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Figure	   3.9:	   Cell-­‐type-­‐specific	   induction	   of	   a	   p21-­‐dependent	   checkpoint	   upon	  
depletion	  of	  Ki-­‐67.	  	  
	  








	   99	  






K.       
   
 
	   100	  
Figure 3.10: Model.  In “Ki-67 sensitive” cells, depletion of Ki67 leads to p21 
induction.  The elevated p21 levels are predicted to downregulate the Rb/E2F 
and DREAM target G1/S cell cycle genes and inhibit DNA synthesis by binding to 
PCNA. Together, these effects delay S phase entry 
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3.4: Discussion 
3.4.1: Cell-type specific responses to Ki-67 depletion 
Our studies show that Ki-67 expression is important for normal S phase 
progression in primary human foreskin fibroblasts, non-transformed fibroblast 
lines (WI-38 and IMR90), hTERT-immortalized BJ fibroblasts, and hTERT-
immortalized RPE1 cells (Bodnar et al., 1998), a human female retinal pigment 
epithelial cell line with a diploid karyotype (Ma et al., 2015). In contrast, in cancer-
derived 293T, U2OS and HeLa cells, depletion of Ki-67 did not cause defects in 
cell proliferation. Therefore, we conclude that Ki-67 is required for normal cell 
cycle progression in some but not all cell lines. Our data distinguish two types of 
responses to depletion of Ki-67 in human cells, depending on whether cells are 
able to mount a p21-dependent checkpoint. 
hTERT-BJ fibroblasts were sensitive to Ki-67 depletion in our assays; 
however, a previous study indicated that shRNA-mediated Ki-67 depletion did not 
affect hTERT-BJ cell cycle re-entry after starvation (Sobecki et al., 2016). We 
note that two other assays used in the previous study are insensitive to the cell 
cycle progression delays that we observe upon Ki-67 depletion. First, one-
dimensional flow cytometry of propidium iodide-stained asynchronous 
populations cannot detect the S phase delays we detect in BrdU labeling 
experiments; second, a 3 hour EdU pulse is too long to capture the 2-hour S 
phase entry delay. Together, our data indicate that the effects of Ki-67 on S 
phase progression are transient in sensitive cell types and therefore best 
observed using short pulses of labeled deoxynucleotides.  
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3.4.2:  Characteristics of checkpoint activation caused by Ki-67 depletion 
Meta-analyses of our RNAseq data showed that Ki-67 depletion in 
hTERT-RPE1 cells resulted in frequent repression of Rb/E2F-regulated, G1/S 
expressed genes. However, depletion of the Rb checkpoint protein only partially 
relieved transcriptional repression and did not restore normal percentages of S 
phase cells, indicating that additional factors were responsible for the altered cell 
cycle profile in Ki-67 depleted cells.  
A strong candidate for such a factor is the DREAM complex, which 
represses G1/S-expressed cell cycle genes in a p21-dependent manner(Fischer 
et al., 2016; Benson et al., 2014). We noticed frequent downregulation of 
DREAM complex targets in Ki-67-depleted cells, which lead us to test whether 
sensitivity to Ki-67 depletion was also p21-dependent. Notably, both the 
transcriptional alterations and cell cycle perturbations caused by Ki-67 depletion 
were partially relieved by simultaneous depletion of p21. Importantly, cell lines 
that induce p21 upon Ki-67 depletion are those that inhibit transcription of DNA 
replication genes and delay entry into S-phase. Thus, this study implicates a p21-
dependent checkpoint in cells sensitive to Ki-67 depletion.  
A recent study shows that PD0332991, a small molecule CDK4/CDK6 
inhibitor (CDKi), depletes Ki-67 protein levels in some but not all cell lines 
(Sobecki et al., 2017). In “CDKi-sensitive” cells, this compound causes G1 cell 
cycle arrest via an Rb-mediated checkpoint, inhibiting Ki-67 and cyclin A gene 
transcription while proteasome-mediated degradation destroys existing Ki-67 
protein molecules. CDKi-sensitivity appears similar to many of the responses we 
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observe upon Ki-67 depletion, and CDKi-sensitive cells include IMR90 and 
primary fibroblasts that we found to be “Ki-67 sensitive”. MCF7 breast 
adenocarcinoma cells are also CDKi-sensitive (Sobecki et al., 2017), and we find 
that upon Ki-67 depletion MCF7 cells induce p21 and down-regulate DNA 
replication genes. In contrast, HeLa and U2OS cells are not sensitive to either 
CDKi or Ki-67 depletion. Thus, depletion of Ki-67 via CDKi treatment (Sobecki et 
al., 2017) or via siRNA (this work) often leads to similar outcomes.  
However, there is a counterexample to these correlations. CDKi treatment 
blocks S phase entry and depletes Ki-67 in MDA-MB-231 breast 
adenocarcinoma cells (Sobecki et al., 2017). In contrast, upon Ki-67 depletion, 
MDA-MB-231 cells did not display either p21 induction or transcriptional down-
regulation of S phase genes. Therefore, proteasome-mediated degradation of Ki-
67 via CDK4/6 inhibition is not equivalent to siRNA-mediated Ki67 depletion in all 
cell types. We hypothesize that a key difference is related to induction of p21 in 
“Ki-67-sensitive” cell lines. p21 contributes to G1/S arrest via multiple 
mechanisms. As a CDK inhibitor(Xiong et al., 1993; Gartel and Radhakrishnan, 
2005), p21 blocks CDK-mediated Rb phosphorylation thereby inhibiting E2F-
driven transcription(Brugarolas et al., 1999). Likewise, it maintains activity of the 
transcriptionally repressive DREAM complex which contain Rb-related 
p107/p130 “pocket protein” subunits(Fischer et al., 2016; Sadasivam and 
DeCaprio, 2013).  p21 also directly interacts with PCNA and directly inhibits DNA 
synthesis (Waga and Stillman, 1998). Therefore, the lack of p21 induction in 
MDA-MD-231 cells may be the key factor explaining the lack of “Ki-67 sensitivity” 
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in this cell line. Future experiments will be required to determine whether the 
activation of the DREAM complex or direct inhibition of DNA synthesis machinery 
is more important for the “Ki-67-sensitive” phenotype associated with p21 
induction.  
Regarding the defect in p21 induction in MDA-MB-231 cells, we note that 
they express a gain-of-function R280K allele, which dominantly blocks p21 
induction (Junk et al., 2008). Thus, p53 status is likely a critical aspect of the 
different cell cycle responses to Ki-67 depletion in many cell lines. However, 
sensitivity to Ki-67 depletion cannot always be predicted strictly by p53 status. 
For example, HCT116 cells express wild-type p53 (Junk et al., 2008) but are not 
sensitive to the CDKi PD0332991 (Sobecki et al., 2017), or to Ki-67 depletion 
(Fig. 9J). Because Ki-67 expression predicts the differential response of different 
cell lines to CDKi treatment during xenograft tumor formation (Sobecki et al., 
2017), understanding how different checkpoint mutations alter Ki-67 expression 
and sensitivity to its depletion are important goals for developing stratified 
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Table	  3.1:	  The	  summary	  of	  similarities	  and	  differences	  between	  CDKi	  sensitivity	  and	  Ki-­‐67	  sensitivity	  Cell	  line	   Rb	  status	   p53	  status	   p21	  induction	   CDKi	  	  sensitivity	   Ki-­‐67	  sensitivity	  	  IMR-­‐90	   +	   +	   +	   +	   +	  
MCF-­‐7	   +	   +	   +	   +	   +	  
HDF	   +	   +	   +	   +	   +	  
hTERT-­‐RPE1	   +	   +	   +	   unknown	   +	  MDA-­‐MB-­‐231	   +	   -­‐	   -­‐	   +	   -­‐	  MDA-­‐MB-­‐436	   -­‐	   -­‐	   unknown	   -­‐	   unknown	  HCT116	   +	   +	   -­‐	   -­‐	   -­‐	  
HeLa	   low	   +	   -­‐	   -­‐	   -­‐	  






	   106	  
3.5: Material and Methods 
3.5.1: Flow cytometry 
Cells were pulsed labeled with 50mM bromodexoyuridine (BrdU) for 
indicated time. Cells were then washed twice with PBS, fixed in 70% ethanol at 
4OC for 1 hour. Post-fixed cells were denatured in 2N HCl/0.5% Triton-X for 30 
minutes. After denaturation, cells were washed once in 0.1M sodium tetraborate 
for 2 minutes and once in PBS/1%BSA. After that, cells were resuspended in 
anti-BrdU antibody for 1hr followed by three washes with 0.5% Tween 
20/1%BSA/PBS. The cells were incubated with secondary antibody for 30 
minutes and counterstained with propidium iodide at the concentration of 50 
mg/ml in PBS and acquired on a LSR II (BD Biosciences). The data was 
analyzed with FlowJo software (TreeStar, Ashland,OR) 
3.5.2: RNA isolation and real time quantitative PCR 
Total RNA from cells 72 hours post transfection was isolated using Trizol 
(Invitrogen 15596026) following manufacturer’s instructions and purified using 
the RNeasy kit (Qiagen 74104). One microgram of RNA was subjected to 
reverse transcription with SuperScript II Reverse Transcriptase (Invitrogen 
18064014). qPCR reactions were performed on an Applied Biosystem 
StepOnePlus machine (Life Technologies) using FAST SYBR mix (KAPA 
Biosystem).  The program used is as follows: hold 98°C for 30 s, followed by 40 
cycles of 95°C for 10 s and 60°C for 30 s. All the signals were normalized with 
beta-actin as indicated in the figure legends and the 2−ΔΔCt method was used for 
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quantification (Life technologies). Primer sequences are designed by 
Primer3Plus software (Untergasser et al., 2012; Andreas Untergasser et 
al.,2012).  
Table	  3.2:	  Primers	  for	  q-­‐PCR	  
This table shows the forward and reverse primers used for q-PCR to particular 
targets used in Chapter III. 
Target	   Forward	  Primer	   Reverse	  Primer	  MCM4	   TGACCGTTACCCTGACTCAA	   CACACTTGGCACTGGAAGAA	  
MCM5	   CTGGGGGAGTACTGGATTGA	   ATGACCTGGATGTCCTGGAG	  
RFC1	   GACACAGAAGCGGGAGAAAC	   TGATGACTTGGAATGTTGCTG	  
RFC4	   GACCACCTGGAACTGGAAAA	   CTGAGCGACTTCCTGACACA	  
p21	   CAGCAGAGGAAGACCATGTG	   GGCGTTTGGAGTGGTAGAAA	  
Ki-­‐67	   TGCTCTGGGTTACCTGGTCT	   GGCTTCTCCCCTTTTGAGAG	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3.5.3:RNAseq: sample preparation and analysis 
RNA was isolated as described above. Libraries from two replicates were 
constructed in a strand-specific manner via dUTP method by BGI and sequenced 
using Illumina-HiSeq 2000/2500 platform (BGI) as single-end 50-base reads.  
29M and 31 M mapped reads were obtained from two controls, 28M and 29M 
were from two Ki67 knockdown replicates. Reads were aligned to the human 
reference genome (hg19) using Tophat 2.0.14. (Trapnell et al., 2009; Kim et al., 
2013). Differential expression analysis was determined by cufflinks 2.2.1 
(Trapnell et al., 2010). In addition, the reactome analyses were performed using 
Bioconductor package ChIPpeakAnno (version 3.2.0) (Zhu et al., 2010; Zhu, 
2013). Genes that showed differential expression with p value < 0.05 between 
control and Ki-67 depletion samples were selected for the reactome analysis.  
3.5.4: Accession Numbers 
The data discussed in this publication have been deposited in NCBI's 
Sequence Read Archive (SRA, http://www.ncbi.nlm.nih.gov/sra/) and are 
accessible through SRA Series accession number SRR4252548, SRR5535471, 
SRR5535778, and SRR5535934. 
3.5.5: Antibodies  
mouse anti-p21 antibody (Abcam ab109520) at 1:1000 for immunoblotting 
mouse anti-Rb antibody(4H1) cell signaling 9309 at 1:1000 for 
immunoblotting 
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CHAPTER IV: DISCUSSION 
4.1: Scientific questions addressed by this dissertation  
The mechanism by which perinucleolar heterochromatin attaches to the 
nucleolar periphery are not well understood, and even less is known if any NAD 
associations are sensitive to the G1/S checkpoint status of the cells examined.  
Previous work from the Kaufman group demonstrates that Ki-67 promotes 
localization of alpha-satellite 17 to the nucleolus(Matheson and Kaufman, 2017a; 
Matheson and Kaufman, 2015).  This leads to the question of whether Ki-67 
targets other genomic regions to the nucleolus.  Inactive X chromosome 
represents a premier example of facultative heterochromatin formation and 
maintenance. In unsynchronized female hTERT-RPE1 cells, depletion of Ki-67 
significantly reduces the association of Xi to the nucleolus. This is accompanied 
by increased transcription of Cot-1 hybridizing DNA repetitive elements and 
reduced H3K27me3 and H4K20me1 enrichment on the Xi in a subset of cells in 
which the Xi was localized away from the nuclear periphery. In contrast to 
hTERT-RPE1 cells, no alteration of perinucleolar Xi localization or erosion of 
heterochromatin features is observed in 293T cells. Therefore, the impaired 
maintenance of epigenetic features in hTERT-RPE1 cells on non-laminar Xi 
chromosomes could indicate the laminar associations protect from this type of 
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erosion. Alternatively, these observations could indicate that movement away 
from the lamina is required for downstream alteration. 
In MEF cells, perinucleolar localization of Xi is S phase dependent(Zhang 
et al., 2007). To study the dynamics of the association, I synchronized the 
hTERT-RPE1 cells at the G/S transition and tracked the Xi –nucleolus 
association through the S phase progression.  In the Ki-67 depleted cells, the 
frequency of Xi-nucleolar association peaks later than the control cells. I found a 
~ 2hrs delay of S phase entry which correlates with the delay of interaction peak.  
Although Ki-67 expression is tightly correlated to proliferation, its 
requirement for cell proliferation has been questioned.  I applied two-dimensional 
fluorescence –activated cell sorting (FACS) analysis to examine the cell cycle in 
hTERT-RPE1 cells. 15 minutes pulse of labeled deoxynucleotides is sensitive to 
detect changes of proportion of S phase cells. In hTERT-RPE1 cells, depletion of 
Ki-67 indeed reduced the proportion of cells in S phase.  
To understand the mechanism of regulation, I applied RNA-seq analysis of 
control and Ki-67 depleted hTERT-RPE1 cells. I observed coordinated 
downregulation of DNA replication genes.  I further analyzed Ki-67 contribution to 
cell cycle on multiple non-immortalized and tumor derived cell lines.  My data 
distinguished two types of response to Ki-67 depletion in human cells, depending 
on whether cells are able to mount a p21 dependent checkpoint. This discovery 
yields many more questions:  With respect to the cell cycle, do Ki-67 depleted 
cells accumulate DNA damage? In addition to G1/S checkpoint, is G2/M 
checkpoint impaired? With respect to the heterochromatin compartment, how are 
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NAD-nucleolus interactions governed by cell cycle regulation? In the following 
chapter I will discuss experiments that may answer these questions and future 
studies that build upon these results.  
4.2: How does Ki-67 promote NADs organization?   
Ki-67 affects nucleolar localization of heterochromatin in multiple ways. 
The first of these appears to be restricted to G1/S checkpoint-proficient cells. By 
regulating the S phase progression in p21 checkpoint proficient cells, Ki-67 
affects the S phase dependent association between Xi and the nucleolus.  
Paternal Kcnq locus visits the nucleolus during S phase in placental cell 
(Mohammad et al., 2008).  It is likely that Ki-67 can also influence its localization 
in the same manner as Xi.  
Not all heterochromatin effects of Ki-67 depletion are dependent on cell 
cycle checkpoints. For example, depletion of Ki-67 in HeLa cells does not alter 
cell cycle, but the nucleolar association frequency of alpha satellite DNA was 
significantly reduced(Matheson and Kaufman, 2017a).  Therefore, Ki-67 
promotes NAD localization even in checkpoint-deficient cells. How does Ki-67 
promote these interactions? There are several possibilities that are not mutually 
exclusive.  
First, Ki-67 directly interacts with other NADs targeting elements. CAF-1 
p150, the largest subunit of histone chaperones complex Chromatin Assembly 
Factor-1 (CAF-1) is one candidate. CAF-1 p150 is required for nucleolar 
macromolecular association(Smith et al., 2014). In HeLa cells, CAF-1 p150 
depletion disrupts localization of multiple nucleolar proteins and decreases the 
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association of NADs, including α-satellite DNA, D4Z4 macrosatellites, and the 
array of 5S rDNA(Smith et al., 2014). Proteomics analysis of CAF-1 p150 detects 
Ki-67 as an interaction partner. During the interphase, a subset of CAF-1 p150 
co-localize with Ki-67 and regulates Ki-67 localization(Smith et al., 2014; 
Matheson and Kaufman, 2017a).  These results indicate that Ki-67 and p150 
may act in the same pathway to facilitate NAD targeting.  To test this hypothesis, 
future studies should examine the association between alpha-satellite and the 
nucleolus in the Ki-67 mutant cell lacking p150 binding motif.  
In addition, Ki-67 can interact with chromatin features of NADs. NADs are 
enriched in the repressive histone modifications H3K9me and H3K27me3. In the 
absence of Ki-67, H3K9Me3 and H4K20Me3 become less focally 
clustered(Sobecki et al., 2016). Methylation of H3K9 is recognized by 
HP1(Jacobs and Sepideh, 2002; Nielsen et al., 2002). Ki-67 directly binds HP1 
with high affinity(Scholzen et al., 2002). In HeLa cells, Ki-67 partly overlaps with 
HP1 and ectopic expression of HP1 relocalizes endogenous Ki-67 to the sites of 
high HP1 concentration. It suggests a model which Ki-67 maintains the 
repressive histone modifications of HP1-bound heterochromatin and attach them 
to the nucleolus. Depletion of Ki-67 may interfere with heterochromatin silencing 
marks within the NADs, resulting in mislocalization of NADs loci away from the 
nucleolus. Thus, future studies should map the domains on Ki-67 which are 
required for HP1 interaction or H3K9me3 maintenance.  A series of cell lines with 
endogenous Ki-67 domain mutations can be generated using CRISPR/cas9 
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genome editing technology and NADs localization should be examined in these 
cell lines.  
The LR domain of Ki-67 can bind to DNA (Takagi et al., 1999; Scholzen et 
al., 2002) and Ki-67 may recognize primary of sequences of DNA. There has 
been no systematic analysis of NAD relocalization in repsonse to Ki-67 depletion, 
so it is not known if there are unforessen specificities regarding this activity. It will 
be particularly interesting to know if any NAD associations are sensitive to the 
G1/S checkpoint status of the cells examined. The lack of ChIP grade antibodies 
for Ki-67 did not allow a ChIP-based approach to map its binding sites. A TAG-
proteogenomic approach provide unbiased information on assoication with 
specific  histone variants and modifications as well as the genomic binding 
regions of Repo-Man(de Castro et al., 2017). Similarly, GST-tagged, full length 
Ki-67 or GST alone can be used as bait to isolate HeLa nucleosomes with high 
affinity for Ki-67. After elution, the chromatin bound fraction can be used  either to 
separate the histone bands for mass spectrometry analysis or to extract DNA for 
sequencing. An tag such as FLAG or v5  can be inserted into the endogenous 
loci of Ki-67 by CRISPR/cas9 genome editing technology. Through these 
experiments whether Ki-67 prefers to target specific sequences or sequences 
with speficic chromatin features to  nucleolus can be identified. 
4.3: Further investigation into NADs organization during differentiation and 
cell cycle   
Nuclear reorganization regulates developmental timing and gene 
expression. During development, the repressive compartments often change 
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form and composition(Almouzni and Probst, 2011; Peric-Hupkes et al., 2010). 
The subsequent differentiation of mouse embryonic stem cells (mESC) via 
lineage-committed neural precursor cells (NPC) into terminally differentiated 
astrocytes (AC) represents a good system for studying NAD organization during 
development(Peric-Hupkes et al., 2010). In this system, future studies should 
compare NADs identified via deep sequencing of nucleoli purified from mESC, 
NPC and AC.  
Another system is to compare olfactory receptors between basal and 
sustentacular cells from the main olfactory epithelium and olfactory sensory 
neuron (OSNs). Olfactory receptor genes were considered to be NADs by deep 
sequencing of purified nucleoli from somatic cells(Koningsbruggen et al., 2010; 
Németh et al., 2010; Dillinger et al., 2016). As the neurons develop, one of 2800 
receptor genes is expressed whereas the remaining receptors are repressed and 
clustered with one another into heterochromatin loci(Imai et al., 2010). It will be 
interesting to investigate whether repressed genes or expressed genes associate 
with different nuclear compartments during neuron development. 
Although the FISH-microscope experiments have identified two S phase 
related NADs, an unbiased genome-wide analysis of NADs dynamics during the 
cell cycle has not reported.  Two methods can address this question from 
population level and single cell level.  
The nucleolus can be purified from synchronized cell population.  
Beginning in telophase, nucleoli reforms around individual NORs and form 
multiple small nucleoli. Nucleolar fusion then occurs, resulting in the formation of 
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larger mature nucleoli in late G1 phase (Pederson, 2011; McStay, 2016). So far 
no reports show successful biochemical purification of immature nucleoli, thus 
purifying nucleoli from S and G2 phase is a major focus. 
NADs are heterogeneous in their chromatin compositions, regulatory 
functions, and the way they interact with the nucleolus. Therefore, single-cell 
mapping may reveal the NAD-nucleolus interactions that cannot be easily 
inferred from population-averaged maps. Combinations of Dam-Lamin B1 and 
m6A tracer enable the visualization of LAD-NL interactions in individual cell(Kind 
et al., 2013b).  However, major difficulties in performing nucleolar DamID arise 
due to the structure of the nucleolus. Unlike the nucleus, the nucleolus is a 
nonmembrane-bound subnuclear organelle. Nucleolus continuously exchanges 
macromolecules with the nucleoplasm. Imaging nucleolar protein-fluorescent 
protein fusions in live cells revealed that most nucleolar proteins shuttle between 
the nucleolus and the nucleoplasm at fast pace(Pederson and Tsai, 2009; 
Mangan et al., 2017). For a DamID fusion protein, the best candidate protein 
should possess the following characteristics. First, the protein should have a 
relatively long retention time in the nucleolus. Second, the protein should reside 
in the granular component (GC) that is the outer regions of the nucleolus. 
Nucleophosmin/B23 is one candidate. Nucleophosmin/B23 is abundant in the GC 
of the nucleolus(Sirri et al., 2008). When S125, the CDK2 phosphorylation site is 
mutated, S125A-B23 is less mobile and has a higher affinity for the nucleolus 
(Negi and Olson, 2006). Since nucleolus itself is a highly dynamic structure, it is 
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possible that NADs have a relatively higher motility than LADs on average during 
the interphase.   
4.4:  Why association occurs specifically in S-phase?  
During S phase, proper chromatin states are re-established and 
epigenetic modifications are transmitted to the daughter strands. Intuitively, 
repressive perinucleolar localization may facilitate de novo incorporation of 
repressive chromatin factors. But other nuclear functions may be related to this 
process. 
First is DNA replication timing.  NADs show a strong overlap with domains 
replicating late during S phase. However, it is not clear whether it reflects the 
heterochromatic nature of NADs or whether nucleolus interactions can at least in 
part dictate DNA replication timing.  For example, late replicating DNA on large 
chromosomes tends to localize to the periphery(Ragoczy et al., 2014). Future 
studies should test whether embedding Xi into larger late replication domains 
would affect localization of integration sites in HT1080 male cells.  
Another possible function is DNA repair. Double strand breaks (DSBs) 
arise spontaneously during DNA replication. In mammalian cells, two repair 
pathways are responsible for DSB: the error prone non-homologous end joining 
pathway (NHEJ) and error free homologous recombination(HR) (Ferguson et al., 
2000; Kolodner et al., 2002). HR occurs mainly in S phase when a sister 
chromatid that can be used as a template for repair is present(Branzei and Foiani, 
2008) . During the G2 phase, both processes can operate. Although HR is a 
main pathway in repairing breaks within heterochromatin (Geuting et al., 2013; 
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Kakarougkas et al., 2013), artificial tethering a DSB site to the NL delays DNA 
damage response and causes a shift from HR repair to NHEJ(Lemaître et al., 
2014). Whether S phase dependent nucleolar localization would influence DNA 
damage response activation and choice of repair pathway is not studied yet. To 
answer this question, future studies should induce the DSB on Xi and follow the 
repair process when it is tethered to NL or nucleolus.  The autosomes bearing 
the Xic transgenes associate with nucleolus in mid-late S phase as endogenous 
Xi did in HT1080 cells(Kelsey et al., 2015). Thus, synchronized S phase cells can 
enrich nucleolus associated Xi. If a LacO array is integrated into the Xic 
transgenes, expression of GFP-Emerin-LacI can reposition Xi transgene to 
nuclear periphery. To create spatially defined DSB, I-SceI locus can be 
integrated to the LacO-Xic and express I-SceI endonuclease under the control of 
a doxycycline-induced promoter(Lemaître et al., 2014). The impact of nuclear 
compartments on DNA damage response efficiency can be assessed by 
comparing the kinetics of induction of γH2AX and 53BP1 via immunostaining. To 
evaluate which repair pathway it chooses, recruitment of Ku80 and XRCC4 is to 
mark NHEJ(Leiber, 2010; Britton et al., 2013) and recruitment of BRCA1, Rad51 
and Rad54 is to mark HR(Chen et al., 2008; Heyer et al., 2010). Furthermore, in 
order to investigate the contribution of NHEJ and HR in repairing the I-SceI 
breaks at the nucleolus, future studies should deplete NHEJ or HR and assess 
the degree of persistent breaks by γH2AX staining 
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4.5:  To investigate how p53 and Ki-67 double depletion leads to lethality 
Co-depletion of p21 suppressed the transcriptional and cell cycle defects 
in diploid hTERT-RPE1 cells upon Ki-67 depletion. As p21 is a downstream 
effector of the tumor-suppressor p53(Fischer et al., 2016), I hypothesized that 
suppression of p53 should also suppress the transcriptional downregulation and 
reduced S population in Ki-67 depleted hTERT-RPE1 cells as p21 did. 
Surprisingly, simultaneous depletion of p53 and Ki-67 results severe cell death 
as observed from crystal violet staining (Fig 3.9K). p53 depletion alone leads to 
modest growth deficiency in hTERT-RPE1 cells. These data suggest that p53 
has p21-independent functions that are essential for viability in the absence of Ki-
67. The master tumor suppressor p53 frequently mutated in human cancers 
(Petitjean et al., 2007). Whereas p53 mutations are not directly 
druggable(Reinhardt et al., 2009), its synthetic lethal partners may implicate 
direct drug targets. Therefore, discovering of the mechanisms that govern the 
p53-Ki-67 synthetic lethality has the potential therapeutic implications.  I 
hypothesize that Ki-67 depleted cells represent a particularly sensitive context in 
which the importance of p53 is exacerbated.  
First, loss of p53, if in conjunction with ATR/ATM suppression, would 
continue proliferation of damaged cells that finally confers apoptosis(Reinhardt et 
al., 2007). Future studies should analyze whether DNA damage checkpoints are 
intact in Ki-67 depleted cells. In both Ki-67 wild type or Ki-67 depleted cells, upon 
commonly used DNA-damaging agents cisplatin, doxorubicin and camptothecin, 
γH2AX phosphorylation, 53BP1 foci and cleaved caspase-3 can be visualized by 
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immunofluorescence(Lukas et al., 2011b; Lukas et al., 2011a; Gurpinar and 
Vousden, 2015) . Phospho-Chk1 ad phospho-Chk2 can be quantified by 
immunoblotting(Gurpinar and Vousden, 2015). Cells with co-depletion of 
MAPKAP Kinase-2 (MK2) and p53 lost intra-S and G2/M checkpoint following 
treatment of DNA damage reagent. Thus, the phosphorylation status of MK2 will 
also be examined(Reinhardt et al., 2007).  
In addition, loss of the G2/M checkpoint in the context of p53-deficiency 
sensitizes cells to various forms of DNA damage(Bunz et al., 1998). Therefore, 
future studies will determine whether Ki-67 depleted cell has a functional G2/M 
checkpoint.  Under genotoxic stress such as cisplatin or irradiation that activates 
G2/M checkpoint, the progression of Ki-67 depleted cells into M phase can be 
monitored by the proportion of mitotic cells. It can be performed by FACS 
analysis of propidium iodide-stained cells. H3 pSer-10 or pSer-28 level is another 
mitotic index that can be quantified by immunoblotting(Johansen and Johansen, 
2006; Goto et al., 1999).  
Third, recent studies have shown that p53 null but not p21 null cells are 
deficient in resolving DNA topological conflicts between DNA replication and 
transcription(Yeo et al., 2016).  It renders p53 deficient cells sensitive to 
topoisomerase II inhibitor. Depletion of Ki-67 results in increased sensitivity to a 
topoisomerase II inhibitor doxorubicin (Cidado et al., 2016). It is possible that Ki-
67 and p53 double knockdown produces additive and unresolved replication 
stress that leads to cell death. Accumulation of TOP2A-DNA complex is an 
indicator of DNA topological states. It can be detected by dot-plot from CsCl 
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gradient fractionated cell extract(Yeo et al., 2016). Therefore, future studies will 
focus to investigate the formation of TOP2A-DNA complex in Ki-67 depleted cells. 
In addition, the domains of Ki-67 that is synthetically lethal with p53 depletion can 
be mapped and the interactors involved in this process can be found out. 
4.6:  Whether Ki-67 depletion induces DNA damage and when does the 
DNA damage occur during the cell cycle? 
Induction of p21 and delayed S phase entry in hTERT-RPE1 cells indicate 
the cells impose a response program to repair damaged DNA or to prevent 
further proliferation of damaged cells. However, one study did not detect 
accumulation of 53BP1 foci in Ki-67 depleted HeLa cells(Booth et al., 2014). It 
may be due to the blunted DNA damage response in highly transformed cells 
since we did not detect alterations of cell cycle and transcription in virally 
transformed HeLa cell line. In addition, previous study focused on the mitotic 
cells, it is possible that at the time point they investigated, cells that underwent 
DNA damage do not have enough reaction time to form damage foci but the 
lesion will transferred to daughter cells where they become sequestered in 
53BP1 nuclear bodies(Lukas et al., 2011a). To address this question, cells 
throughout the cell cycle would be immunostained for γH2AX phosphorylation 
and 53BP1 foci(Lukas et al., 2011b; Lukas et al., 2011a; Gurpinar and Vousden, 
2015). Chk1 and Chk2 checkpoint kinase phosphorylation would be quantified by 
immunoblotting (Gurpinar and Vousden, 2015).   
As to when this damage occurs, there are several possibilities. During 
mitosis, Ki-67’s large size and high density of positive charge rendered it as a 
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surfactant preventing chromosomes from collapsing into a single chromatin 
mass(Cuylen et al., 2016)  Loss of spatial separation between mitotic 
chromosomes impair spindle assembly and chromosome alignment during the 
metaphase. In addition, although Ki-67 depleted cells can continue to divide after 
mitotic defects, the subsequent second division becomes more 
problematic(Booth et al., 2014). During interphase, Ki-67 promotes a subset of 
NAD loci to nucleolar periphery(Booth et al., 2014; Matheson and Kaufman, 
2017a). NADs repositioned away from repressive nucleoli periphery are more 
likely undergoing heterochromatin erosion. Determining the precise phase at 
which damage occurs will be difficult, as damage from preceding phase can 
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Appendix A: CAF-1 p150 does not organize mitotic 
chromosome periphery in mouse cells 
Introduction 
Mitotic chromatin must reorganize and condense for segregation. A 
proteinaceous sheath referred as perichromosomal layer (PCL) coats mitotic 
chromosomes(Hernandez-verdun and Gautier, 1994; Van Hooser et al., 2005).  
Immunocytochemistry revealed that this structure associates with chromosome 
surface that consists of several proteins, including nucleolar protein nucleolin, 
fibrillarin, nucleophosmin and Ki-67, nuclear matrix proteins Ku proteins and 
ribonucleoproteins (RNPs) (Hernandez-verdun and Gautier, 1994; Van Hooser et 
al., 2005). The persistent association of proteins on PCL from prophase till 
telophase implied that they are involved in determining the spatial relationship 
and interaction between chromosome during mitosis and early G1.  Investigating 
the mechanism driving the movement of these proteins from the nucleus to the 
chromosome periphery and back to in the reforming nucleus will link mitotic 
chromosome structure to interphase genome organization. 
Ki-67 is one of the earliest proteins to bind the perichromosomal layer in 
mitosis(Endl and Gerdes, 2000; Saiwaki et al., 2005). On the onset of nucleoli 
disassembly in prophase, Ki-67 relocalizes to the PCL and accumulates on PCL 
until telophase(Takagi et al., 2014). During mitosis, acute depletion of Ki-67 
prevents all nucleolar proteins tested accumulating on the PCL in HeLa 
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cells(Booth et al., 2014). Impaired PCL assembly results in deficient 
nucleologenesis and uneven distribution of nucleolar proteins in the daughter 
cells(Booth et al., 2014).  
CAF-1 p150, the largest subunit of histone chaperone Chromatin 
Assembly Factor (CAF-1) regulate Ki-67 nucleolar localization during interphase 
and normal levels of Ki-67 accumulation on the PCL during mitosis in HeLa 
cells(Smith et al., 2014). This activity was mapped to the sumoylation interacting 
motif (SIM) within p150, which is dispensable for chromatin assembly but 
required for the Ki-67 localization and the association of nucleolus association 
domains (NADs) with nucleolus during interphase(Smith et al., 2014).  
CAF-1 p150 and Ki-67 are highly conserved between human and 
mouse(Kumar et al., 2016).  We began exploring the CAF-1 p150/Ki-67 hierarchy 
in several mouse cell types 
Results 
Ki-67 localization throughout the cell cycle in mouse cell culture 
In human cells, Ki-67 has three distinct nuclear localization patterns, which 
appear at different stages of cell cycle. In the early G1 phase, Ki-67 localizes to 
hundreds of distinct foci, which colocalize with heterochromatic satellite repeats. 
(Bridger et al., 1998). Ki-67 relocalized to the reformed nucleoli during the 
interphase(Verheijen et al., 1989b; Kill, 1996; Traut et al., 2002; Cheutin et al., 
2003). Third, Ki-67 localizes to the PCL during mitosis(Endl and Gerdes, 2000; 
Saiwaki et al., 2005; Booth et al., 2014). Via immunofluorescence, I first 
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examined Ki-67 localization in mouse embryonic stem cells (mESCs) E14 cells. 
In the interphase, I found that Ki-67 is distributed among the whole nucleus (Fig 
A1 Top Right). I did not observed predominant nucleolus localization. During the 
mitosis, Ki-67 robustly associated with the PCL (Fig A1, Top Left). I observed the 
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mESC E14(Top) or NIH 3T3 (bottom) were subjected to immunofluorescence 
using antibodies  recognizing Ki-67 ( Green) and nucleophosmin (red). DAPI 
staining is shown to identify nuclei. Left: a mitotic nuclei. Right: an interphase 
nuclei.  Scale bar 10 μm 
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In NIH3T3 cells, Ki-67 depletion does not relocalize nucleophosmin from 
PCL 
 
In the HeLa cells, Ki-67 is required from the localization of other known PCL 
proteins (Booth et al., 2014). I next investigate whether it is true in NIH 3T3 cells. 
I used RNAi to deplete Ki-67 in NIH3T3 cells and determined distribution of 
endogenous nucleophosmin/B23 in the mitotic cells. Nucleophosmin/B23 
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Figure A.2:  Depletion of Ki-67 does not dislocalize nucleophosmin on 
mitotic chromosomes in NIH3T3 cells 
 
NIH3T3 cells were treated with si scramble (Top) or siRNA targeted Ki-67 
(middle) for 72 hr and were subjected to immunofluorescence using antibodies 
recognizing Ki-67 (green) and nucleophosmin (red). DAPI staining is shown to 
identify nuclei. Scale bar: 10 μm 
 
Figure  A.2: Depletion of Ki-67 does not dislocalize nucleophosmin on mitotic chromosomes in 
NIH3T3 cells 
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Loss of CAF-1 p150 does not impair Ki-67 localization neither in interphase 
nor mitosis 
I then investigate whether p150 regulates Ki-67 localization in the mouse 
cells. In NIH 3T3 and E14 cells, I efficiently depleted p150 via synthetic siRNA 
(Fig A3 D,E).  Because prolonged p150 depletion leads to strong inhibition of cell 
proliferation(Houlard et al., 2006), I limited my acute depletion experiments to the 
first 72h after siRNA treatment when I did not observe alteration in cell growth.  
Upon p150 depletion, I did not observe dispersion of Ki-67 neither in the 
interphase nuclei nor from the PCL during the mitosis in NIH3T3 cells (Fig A3 B, 
C).  In mESC E14 cells, p150 depletion does not alter Ki-67’s accumulation on 
PCL (Fig A3 A). These observations reveal that mouse CAF-1 p150 did not 
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Figure A.3: Depletion of CAF-p150 does not alter Ki-67 localization neither 
in the interphase nor the mitosis in mESC E14 and NIH3T3 cells. 
 
mESC E14 cells were treated with si scramble or siRNA targeted p150 for 72 hr 
and were subjected to immunofluorescence using antibodies recognizing Ki-67 
( green) DAPI staining is shown to identify nuclei. Scale bar 10 μm 
 
A. E14 cells in mitosis 
B. NIH3T3 cells in mitosis 
C. NIH3T3 cells in interphase 
D. Immunoblot analysis of E14 cells treated with the indicated RNA 
depletion reagents 
E. Immunoblot analysis of NIH3T3 cells treated with the indicated RNA 
depletion reagents 
 
Figure	   A.3:	   Depletion	   of	   CAF-­‐1	   p150	   does	   not	   alter	   Ki-­‐67	   localization	   neither	   in	   the	   interphase	   nor	   the	  
mitosis	  in	  mESC	  E14	  and	  NIH3T3	  cells	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Discussion 
Ki-67 has long been reported to localize in the nucleoli in mammalian cells 
during the interphase(Verheijen et al., 1989b; Kill, 1996; Traut et al., 2002; 
Cheutin et al., 2003). In the mouse Swiss-3T3 fibroblasts, by immunostained with 
an affinity-purified polyclonal antibody, Ki-67 is first seen as small foci in the early 
G1 phase and then accumulates as large foci that overlap with nucleolar marker 
fibrillarin until mitosis(Starborg et al., 1996). However, in both mESC E14 and 
NIH 3T3 cells, by using two different mouse Ki-67 antibody, I did not observe the 
predominant nucleolar localization of Ki-67. Instead, in both mouse cell lines, Ki-
67 dispersed within the whole nucleus including nucleoplasm. A subset of it 
accumulates in the heterochromatin regions labeled by DAPI.  
The localization pattern does not alter in either paraformaldehyde fixation 
or methanol/acetone fixation. The specificity of antibodies has been confirmed by 
Ki-67 depletion experiment. In Ki-67 depleted cells, there is a dramatic decrease 
in fluorescence intensity of Ki-67 staining compared with control cells, but the 
signal intensity of B23 does not change, suggesting that reduced Ki-67 signal 
intensity is due to the decreased protein levels which can be specifically detected 
by the antibodies rather than a reflection of overall reduced epitope accessibility 
affected by RNAi. The discrepancy raises the possibility that Ki-67 may have 
different localizations in different cell types.  
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Materials and Methods 
Cell culture methods 
mESCs lines used in this study were E14. E14 was grown under feeder-
free conditions. E14 cells (a kind gift from Dr. Thomas Fazzio) was cultured in 
DMEM- medium (VWR 10-017-CV) with 10% fetal bovine serum (FBS, Hyclone 
#SH30910.03), 1% penicillin/streptomycin, 2mM L-glutamine, 1% nonessential 
amino acids (Corning25-025-CI) and 106 units /L LIF (homemade). The cells 
were split 1:8 every 3days. 
NIH 3T3 were cultured in DMEM medium with 10% FBS, 1% 
penicillin/streptomycin, 5% L-glutamine. The cells were split 1:3 every 2 days 
siRNA experiments 
Cells were transfected with Lipofectamine RNAi MAX (Invitrogen Catalog 
number 13778100) following manufacturer’s instructions.  
For siRNA transfection, 40 nM of either scramble or siKi67 or siCAF-1 
p150 was transfected into 40 × 103 cells. 
The siRNA targeting mouse Ki-67 and mouse p150 is from the collection 
of Silencer Select Predesigned siRNAs (Thermo Fisher Scientific) and targets 
nucleotides 1569-1587 of the cDNA (NM_001081117.2) or nucleotides 2750-
2769 of the cDNA (NM_ 013733.3),  
mouse si-Ki67 sequence is as follows:  
sense CGUUGAUAUCAGCAACUUUtt,  
antisense AAAGUUGCUGAUAUCAACGga 
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mouse CAF-1 p150 sequence is as follows:  
sense CAGACUGUAUGAUCAUAGAtt,  
antisense CGAGUGUGGUCAUUAUCGAtt 
 
Table	  A.1:	  Antibodies	  used	  for	  immunofluorescence	  and	  western	  blotting	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Appendix B: Loss of CAF-1 impairs heterochromatin 
organization and retrotransposon repression in mouse 
embryonic stem cells 
Introduction 
Totipotent cells can generate a full organism including embryonic tissues 
as well as extraembryonic tissues. In the mouse, only the zygote and 2-cell stage 
blastomere are totipotent(Ishiuchi and Torres-Padilla, 2013). Totipotent 2-cell 
(2C)-like cells have also shown to occur spontaneously in embryonic stem cell 
(ESC) cultures at rare frequency(Macfarlan et al., 2012). After five divisions from 
blastomere, mouse embryos reach the blastocyst stage, which is initially 
composed of the pluripotent inner cell mass and differentiated 
trophectoderm(Marikawa and Alarcon, 2009).  The transition from a totipotent 
state to a pluripotent state is accompanied by the massive chromatin 
rearrangement and epigenetic reprogramming, which are required for specific 
gene expression(Guo and Morris, 2017).   
CAF-1 is a three-subunit protein complex that deposits the DNA 
replication-linked histone H3 variant H3.1 into chromatin during S phase(Krude, 
1995; Shibahara and Stillman, 1999; Smith and Stillman, 1989) . Via interaction 
with HP1 and methyl-CpG binding protein MBD, CAF-1 is important in the 
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heterochromatin establishment and maintenance (Murzina et al., 1999; Quivy et 
al., 2004; Sarraf and Stancheva, 2004; Uchimura et al., 2006; Quivy et al., 2008; 
Houlard et al., 2006). CAF-1 p150 homozygous-null embryos lack chromocenters 
and arrested at the 16-cell stage.   In mESC cells, depletion of CAF-1 p150 
displayed similar abnormal heterochromatin organization (Houlard et al., 2006). 
These results indicate that CAF-1 plays a vital role during early embryonic 
development. Loss of chromocenters is a landmark feature of 2-cell stage(Probst 
et al., 2007).  Here, I investigated how CAF-1 affects totipotency.  
Results 
Acute depletion of CAF-1 leads loss of chromocenters and transcriptional 
activation of major satellite in mouse embryonic stem cells 
To examine the function of CAF-1 in mouse cells, I transfected siRNA 
which targeted the large subunit of CAF-1 p150 in mouse embryonic stem cells 
(mESCs) E14. Significant knockdown was achieved by 48 hr after transfection 
(Fig B1 B). I did not observed strong inhibition of cell proliferation at this time 
point. Prolonged p150 depletion leads to cell death; therefore, I limited my acute 
depletion experiment to the first 48h after siRNA treatment.  
The heterochromatin organization of cells lacking CAF-1 was compared 
with cells treated with control siRNA. In mESCs, the pericentric heterochromatin 
domains cluster together and form higher-order chromatin structure termed 
chromocenters, which are visualized as DAPI-dense foci in interphase nuclei 
(Guenatri et al., 2004). In control mESCs treated with scramble siRNA, I 
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observed the well-defined DAPI-stained foci.  As previous reported, these 
structures were not detected in p150-depleted mESCs E14 cells (Houlard et al., 
2006)(Fig B1 A).  
In mouse, pericentric and centric chromosomal regions are mainly 
composed of large blocks of major and minor satellite repeats. To address 
whether the altered chromocenter morphology leads to deficiency of transcription 
repression, I analyzed the transcriptional activity of pericentric regions by RT-
PCR. Depletion of p150 resulted in a strong upregulation of major and minor 
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Figure B.1:  Loss of CAF-1 p150 results in severe alterations of 




A: Abnormal heterochromatin organization in CAF-1 p150 depleted mESCs E14. 
mESC E14 were transfected with si scramble or siRNA targeted mouse p150. 
DAPI staining is shown to identify nuclei (Blue). In the mESC transfected with si 
scramble, chromocenters are visualized as DAPI-dense foci. In the mESC 
transfected with si p150, DAPI-dense foci were barely detectable. Scale Bar 10 μm 
B. RNAi knockdown efficiency for p150 was confirmed by western blot. The 
whole cell extracts after the siRNA transfection were analyzed with the indicated 
antibodies 
C. RT-qPCR analysis of major and minor satellites after p150 knock down. 
RT-qPCR measurements are presented as fold change relative to the scramble 
siRNA control after normalization. Data are mean ± std. dev. of 3 biological 
replicates 
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Figure	  	  B.1	  Loss	  of	  CAF-­‐1	  p150	  results	  in	  severe	  alterations	  of	  heterochromatin	  organization	  in	  mESC	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CAF-1 repressed transcription of endogenous retrotransposons in mouse 
embryonic stem cells 
Loss of chromocenters and activation of the major satellite repeats are the 
hallmark features of totipotent cells(Probst et al., 2007). I therefore ask if CAF-1 
depletion affects the expression of 2-cell specific genes in mESCs E14 cells.  
RNAi for p150 indeed resulted in strong upregulation of the 2-cell specific 
transcripts Zscan4, Eif1a, as well as MERVL (Fig B2), a particular 
retrotransposon whose expression peaks in two-cell stage embryo and 
depressed after implantation. Other active retrotransposons such as IAP and 
LINE1 were not significantly unaffected (Fig B2), suggesting that p150 depletion 
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Figure B.2: CAF-1 p150 depletion specifically affects 2C-cell transcripts in 
mESC E14 cells 
RT-qPCR analysis as Figure B.1 
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Discussion 
Several lines of evidence put CAF-1 in the center of cellular plasticity. One 
study reported that depletion of either p150, or p60, two different subunits of 
CAF-1 complex significantly increased the proportion of 2C-like cells(Ishiuchi et 
al., 2015). 2C-like cells displayed several properties of totipotent 2C cells in the 
ESC cultures.  Depletion of CAF-1 leads to increased H3.1/H3.2 mobility and 
higher levels of specific 2C-like transcription (Ishiuchi et al., 2015). Another study 
shows that by suppressing CAF-1 dependent nucleosome assembly, the efficacy 
of reprogramming of mouse fibroblasts to induced pluripotent stem cells (iPS 
cells) has increased by several orders of magnitude(Cheloufi et al., 2015). The 
increased reprogramming efficiency results from a more accessible chromatin 
structure upon CAF-1 p150 depletion. It facilitates association of transcription 
factors at promoters of pluripotent factors and depletion of H3K9me3 at 
reprogramming –resistant regions. These results strongly suggest that by 
removal of the basic unit of the chromatin itself, probably concomitantly erasing 
the epigenetic and other chromatin features, prime cell at a state with more 
plasticity.  
It is unclear how does newly established global “open chromatin structure” 
result in transcriptional depression at specific promoter elements. Transcription 
repression is maintained through DNA methylation or repressive histone 
modifications or both. It is possible that different regions rely on different 
mechanisms thus have different sensitivity to histone disturbance. For example, 
in the mESC cells, depletion of CAF-1 dilutes nucleosome, concomitantly dilutes 
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repressive histone modification on MERVL, thus derepresses the MERVL and 
favors the transition from ESC to 2C-like cells (Ishiuchi et al., 2015)while during 
the morula stage, depletion of CAF-1 does not alter the MERVL 
expression(Hatanaka et al., 2015). The repression mechanisms of MERVL 
between morula and blastocyst will help to elucidate the differences.   
Materials and Methods 
Table B.1: Primers for q-PCR 
Target	   Forward	  Primer	   Reverse	  Primer	  Zscan4	   GAGATTCATGGAGAGTCTGAC
TGATGAGTG	   GCTGTTGTTTCAAAAGCTTGATGACTTC	  
Eif1a	  like	   AACAGGCGCAGAGGTAAAAA	   CTTATATGGCACAGCCTCCT	  
MERVL	   CTCTACCACTTGGACCATATGA
C	   GAGGCTCCAAACAGCATCTCTA	  
IAP	   AAGCAGCAATCACCCACTTTG
G	   CAATCATTAGATGCGGCTGCCAAG	  
LINE1	   GGACCAGAAAAGAAATTCCTC
CCG	   CTCTTCTGGCTTTCATAGTCTCTGG	  
Major	  satellite	   GCACACTGAAGGACCTGGAATATG	   GATTTCGTCATTTTTCAAGTCGTC	  
Minor	  satellite	   TCTCCGAACGCAACATGAAG	   ACACCTTGACGGTGACTTTGG	  
Minor	  satellite	   CATGGAAAATGATAAAAACC	   CATCTAATATGTTCTACAGTGTGG	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